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Quantitative image biomarkers are emerging as a method for precision medical diagnosis.  
Fully-automated computer algorithms are explored to provide clinically useful biomarker 
measurements for the assessment of cardiovascular and lung diseases from low-dose thoracic 
computed tomography (CT) images. The recent regulatory approval of annual lung cancer 
screening (LCS) provides the opportunity for the application of these methods to a large at-risk 
population that will already be receiving annual low-dose chest CT scans. These computer 
algorithms must specifically address the high image noise levels concordant with the low-dose 
imaging protocol. 
Quantitative evaluation of cardiovascular disease is facilitated by automated 
segmentations of cardiac organs (aorta, heart region, pulmonary trunk); primarily coronary artery 
calcification (CAC), a major indicator of coronary heart diseases, is scored. For lung disease 
assessment, the automated detection of interstitial lung disease (ILD) at its earliest detectable 
stage is performed. In addition, CT image quality (noise and calibration) is automatically 
assessed from segmented homogeneous regions for quality control and increased measurement 
precision. 
Automated CAC scores have shown a 0.90 correlation with reference measurements 
provided by radiologists. The automated ILD detection algorithm is able to distinguish between 
early-stage ILD and normal cases with an Area Under the ROC curve of 0.95. The image quality 
assessment method has also shown to be repeatable and robust when evaluated on phantom 
images and a large LCS cohort. 
This research advances the state-of-the-art of computer algorithms for precise region 
 segmentation and biomarker measurements that permit the evaluation of cardiac and lung health 
in the context of LDCT. The successful outcomes of these algorithms have demonstrated the 
possibility of automated chest health monitoring on an annual basis for a large population 
through the LCS process.  
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CHAPTER 1 
 
INTRODUCTION 
 Computer-aided diagnosis (CAD) is the application of computer methods to aid 
physicians in the analysis of medical images. In this dissertation, novel fully-automated CAD 
algorithms have been developed to perform thoracic organ segmentation and quantitative 
biomarker measurement from chest CT images with a focus on the low-dose CT images 
associated with lung cancer screening. The CAD algorithms in this dissertation can be grouped 
into three categories: 
1) Algorithms to segment cardiac organs and measure cardiac disease image biomarkers. The 
cardiac organs include the thoracic aorta, the pulmonary artery trunk, and the general heart 
region. The cardiac biomarkers include the coronary artery calcification (CAC) content, the aorta 
and pulmonary trunk (PT) diameter profile, the cardiac visceral fat content, and the aortic 
calcification (AC) content. Segmentation of cardiac organs take advantage of other adjacent pre-
segmented organs such as the lungs and the fat tissues. The segmented cardiac organs are used as 
masks for the segmentation and measurement of cardiac biomarkers. 
2) Algorithms to characterize three different types of lung region image biomarkers: the 
pulmonary nodule, early-stage interstitial lung disease (ILD), and early-stage pleural thickening. 
For the pulmonary nodule, an algorithm is developed to characterize nodule malignancy using 
image features. Furthermore, different datasets and experiments have been constructed to 
evaluate the impact of nodule size on characterization outcome. For ILD, an algorithm has been 
developed to partition the lung region into equal-volume subsections and a fractional high-
density feature is computed for each subsection to indicate the spatial distribution of ILD related 
lung tissues. For pleural thickening, two different algorithms have been developed to detect two 
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different types of pleural thickening, by measuring the distance between the pleural surface and 
the ribs and by detecting concave regions on the pleural surface. 
3) An algorithm to assess image quality (noise and calibration level) from 3D homogeneous 
regions in CT images. The 3D homogeneous regions are computed using pre-segmented organs 
such as the trachea and the descending aorta (DA). An external air region is also computed. 
Noise is represented as the pixel standard deviation in a homogeneous region and calibration is 
represented as the mean intensity level. Both the global image quality and a per image slice 
quality profile are computed for all three regions. 
 In the following sections, section 1.1 describes the primary target dataset used in this 
dissertation: the low-dose chest CT scans associated with lung cancer screening; section 1.2 
gives literature reviews and discusses technical challenges associated with each main topic of the 
dissertation: cardiac analysis, lung region analysis and image quality assessment; section 1.3 
describes the foundation of all the CAD algorithms in this dissertation: the pre-segmentation of 
other chest organs; section 1.4 gives an overview of the subsequent chapters in the dissertation. 
1.1    Low-dose chest CT from lung cancer screening 
 The annual screening for lung cancer with low-dose computed tomography (LDCT) has 
been approved for reimbursement for high-risk population [1] in 2015. Based on the Centers for 
Medicare & Medicaid Services summary, the eligibility criteria of lung cancer screening (LCS) 
participants include age 55 to 77 years (55 to 80 years recommended by the Unites States 
Preventive Services Task Force (USPSTF) [2]), asymptomatic, tobacco smoking history of at 
least 30 pack-years and current smoker or one who has quit smoking within the last 15 years. 
Using the USPSTF eligibility criteria, Jemal et al. [3] estimated that in 2015, 6.8 million smokers 
were eligible for LDCT screening. However, they have also found that currently only a small 
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percentage of eligible smokers have reported LDCT screening (3.9% in 2015). In the future, 
there will potentially be many more LDCT scans taken annually through LCS. 
Although the primary purpose of LCS is to detect early-stage pulmonary nodules, the 
availability of such a large dataset of whole chest CT scans on an annual basis also provides the 
opportunity for screening for other chest region diseases. Due to the age range and smoking 
history, these LCS participants are typically at high risk of heart diseases [4]. Therefore, it is 
beneficial to provide companion diagnosis using these LDCT scans such as evaluating CAC 
content. The companion diagnosis offers additional disease risk evaluation beyond the detection 
of pulmonary nodules without exposing the participants to additional radiation. 
This dissertation builds upon the research studies and LDCT datasets developed and 
gathered over the past 20 years for LCS. These datasets and studies have enabled the 
development and large-scale evaluation of robust CAD algorithms presented in this dissertation. 
In the following subsections, section 1.1.1 will give more details on the benefits of annual LCS 
and section 1.1.2 will discuss the challenges associated with developing CAD algorithms for 
LDCT. 
1.1.1    Lung cancer and lung cancer screening 
 Lung cancer causes more deaths than any other type of cancer in the US [5]: it is 
estimated that in 2015, 158,040 deaths were caused by lung and bronchus cancer. In fact, lung 
cancer caused about as many deaths as the next four deadliest cancers combined together: colon, 
pancreas, breast and prostate cancers as shown in Figure 1.1. 
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Figure 1.1: Estimated cancer deaths in the US in 2015. 
 It has been established that screening for lung cancer greatly improves lung cancer 
survival rate [6]. The International Early Lung Cancer Action Program (I-ELCAP) investigators 
have shown that among the screening participants who received a diagnosis of lung cancer, 85% 
had clinical stage I lung cancer, the stage where cancers are no larger than 3cm and are confined 
to the lungs [7]. The estimated 10-year survival rate for this subgroup was 88% regardless of 
treatment. Of this stage I lung cancer group, the participants who underwent surgical resection 
within 1 month after diagnosis had an estimated 10-year survival rate of 92%. Compared to the 
much lower survival rate for the general population without screening (17.7% 5-year) [8], lung 
cancer screening greatly increases survival rate. The majority of the lung cancer cases from 
screening are stage I lung cancer, the only stage at which cure by surgery is highly likely. 
 Screening for lung cancer has been approved for insurance reimbursement for eligible 
high-risk population in 2015 by the Centers for Medicare & Medicaid Services [1] (eligible 
criteria include 55-77 years, asymptomatic and tobacco smoking history of at least 30 pack-
years). The screening process involves a baseline LDCT scan. If no nodule is detected, the 
participant takes annual repeat LDCT scans. If nodules are detected, depending on the nodule 
size and solidity, different follow-up procedures will be taken [9]. Although LCS nodule 
management guidelines vary among institutes and associations, the general guideline can be 
simplified as shown in Figure 1.2. 
  5 
 
Figure 1.2: Simplified LCS nodule management guideline. 
1.1.2    Characteristics of low-dose CT 
 The LDCT involved in LCS is typically a thoracic CT scan that covers the whole lung 
region [10]. It usually starts a few millimeters superior to the lungs and ends 1-2 centimeters 
inferior to the lungs. The entire heart region and pulmonary arteries are also covered, providing 
the opportunity to assess additional disease risk factors such as CAC content. Figure 1.3 (a) 
shows an illustration of the anatomical structures in the chest region including lungs, heart and 
major vessels [11]. Figure 1.3 (b) and (c) shows an axial image slice from a LDCT scan using 
different image window settings. Different anatomical structures are also indicated in Figure 1.3 
(b) and (c) including the lungs, the aorta, and the main pulmonary artery. 
          
                 (a)                                         (b)                                                 (c) 
Figure 1.3: Example images for LDCT. (a) illustration of anatomical structures included in 
LDCT; (b) LDCT image slice using lung window; (c) LDCT image slice using abdominal 
window. The pulmonary artery is labeled as PA and the vertebra is labeled as Vert. 
In a similar manner to traditional clinical CT, LDCT is calibrated, and homogeneous 
regions fall into pre-determined Hounsfield Units (HU) ranges [12]. However, the radiation dose 
level is much lower for LDCT compared to clinical CT scans. Ono et al. (2013) [13] reported 
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that the effective dose of LDCT was between 1.3 and 3.4 millisievert (mSv) while that of the 
standard-dose CT was between 8.5 and 14.0 mSv. The USPSTF has reported that the radiation 
exposure associated with LDCT ranges from 0.61 to 1.5 mSv per scan [2]. The lower radiation 
dose results in higher image noise. Vardhanabhuti et al. (2013) [14] compared the image noise 
level of standard and low-dose chest CT using different reconstruction schemes and have found 
that when the mean effective dose was 3.7 mSv, the filtered back projection (FBP) reconstructed 
scans had a mean image noise of 26.9 HU and when the dose was decreased to 0.9 mSv, the FBP 
scans’ image noise increased to 51.8 HU. Figure 1.4 shows example images in datasets used in 
this dissertation. The cardiac region noise is 22 HU in the standard-dose image shown in (a) and 
35-48 HU for the low-dose images shown in (b) and (c). Therefore, most established computer 
algorithms designed for standard-dose CT analysis do not translate well to low-dose CT images. 
Low-dose CT image analysis requires novel noise-robust approaches and methods. 
           
             (a)                               (b)                               (c) 
Figure 1.4: Example cardiac regions with different levels of noise. (a) standard-dose CT (aorta 
noise=22HU); (b) low-dose CT (aorta noise=35HU); (c) low-dose CT (aorta noise=48HU). 
1.2    Computer aided diagnosis in low-dose CT: literature review and challenges 
 CAD is playing an increasingly important role in medical research and clinical practice. 
Most of the quantitative CAD systems today are semi-automated, requiring user interaction such 
as manual annotation of a seed region or manual correction of computer outcomes. Fully-
automated CAD does not produce intra-observer variations and, if well-designed, can be more 
sensitive and efficient in the detection of subtle structures easily missed by human such as 
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pulmonary nodules [15]. Zhao et el. (2012) [15] compared the performance of double reading 
versus CAD in the detection of pulmonary nodules in LDCT and have found that the sensitivity 
of nodule detection was 78.1% for double reading and 96.7% for CAD. Beyer et al. (2007) [16] 
compared the reading time of pulmonary nodule detection from CT scans using CAD as a 
concurrent reader. They have found that reading time was significantly shorter for using CAD as 
a concurrent reader (mean reading time 274s per case) compared to reading without CAD (mean 
reading time 294s per case) without significant difference in sensitivity for nodules size 3mm 
and above. 
 Fully-automated CAD is the focus of this dissertation. Compared to semi-automated 
approaches, full-automation is expected to have a more efficient workflow without the need of 
manual adjustments or corrections, therefore providing the foundation for higher quality 
healthcare. All segmentation and biomarker measurement algorithms presented in this 
dissertation are fully-automated and only require the CT scan and its Anatomy Label Map as 
inputs. The Anatomy Label Map will be introduced and defined in section 1.3. 
 The three major topics of this dissertation, which will be reviewed in the following 
subsections, are: 
1) fully-automated computer algorithms for the segmentation of cardiac organs and measurement 
of cardiac disease related image biomarkers from LDCT; 
2) fully-automated computer algorithms for the measurement of lung disease related image 
biomarkers from LDCT; 
3) a fully-automated computer algorithm to assess image quality (noise and calibration) from 
homogeneous regions in CT scans. 
In this section, relevant state-of-the-art CAD algorithms are reviewed with a special focus 
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on those related to LDCT. Section 1.2.1 reviews cardiac region CAD algorithms; section 1.2.2 
reviews lung region CAD algorithms; section 1.2.3 reviews image quality assessment algorithms. 
1.2.1    CAD in the cardiac region 
CAD analysis in the cardiac region typically follows two steps: first, the relevant cardiac 
organs are segmented; then, based on the segmented regions, image biomarkers are measured 
such as the heart volume or the amount of calcium each coronary artery contains. The automated 
cardiac CAD algorithms in this dissertation also follow these two general steps: first cardiac 
organs are segmented using spatial modelling and constraints provided by other adjacent pre-
segmented organs such as the lungs, bones and fatty tissues; then cardiac image biomarkers are 
measured based on the segmented organs. The CAD algorithms are designed for LDCT scans 
although they are also applicable to standard-dose non-contrast chest CT scans. 
Cardiac segmentation starts from the well-defined aorta region: cylinder tracking is used 
to determine the approximate aorta location and ray casting based surface refinement is used to 
determine the final aorta surface. The segmented aorta then provides constraints to the PT and 
heart region. The PT is segmented using a method similar to that used for the aorta. The heart 
region is defined based on constraints from adjacent organs. Then the segmented heart region is 
used as a mask to extract CAC. Based on the segmented organs, biomarkers are automatically 
measured such as the CAC content and aorta diameter profile. A complete cardiac segmentation 
visualization is shown in Figure 1.5. 
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                (a)                                    (b)                                      (c) 
Figure 1.5: Cardiac segmentation visualization with aorta (red), heart region (green) and 
pulmonary artery trunk (blue). (a) coronal view; (b) and (c) show axial slices. 
Traditionally cardiac segmentation and measurement algorithms are often designed for 
CT angiography (CTA) scans, gated cardiac CT scans, or contrast-enhanced CT scans because in 
these scans the cardiac region is highly visible and the boundaries can be detected with little 
ambiguity. For instance, Ecabert et al. (2008) [17] performed fully-automated heart chamber 
segmentation in contrast-enhanced CT using a model-based approach. Kelm et al. (2011) [18] 
performed the fully-automated detection of coronary stenosis in CTA scans by estimating 
coronary vessel location and size and performing classification. Wolterink et al. (2015) [19] 
automatically segmented and labeled CAC in ECG-triggered cardiac CT scans using feature 
classification. However, in the context of LDCT, cardiac regions such as the heart and coronary 
arteries do not have clearly defined boundaries and cannot be robustly segmented. Figure 1.6 (a) 
shows a contrast-enhanced CT image heart region where the individual heart chambers can be 
clearly seen and Figure 1.6 (b) shows a heart region in a LDCT scan where only the general heart 
fat transition boundary is visible. Furthermore, LDCT from LCS are not ECG-gated, which 
further increases the difficulty in segmenting small structures such as the coronary arteries or 
extracting meaningful image features. Figure 1.6 (c) shows a clearly-defined coronary artery in a 
gated standard-dose CT scan while the coronary artery in the same location in a LDCT has a 
more blurred boundary as shown in Figure 1.6 (d). 
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              (a)                          (b)                             (c)                           (d) 
Figure 1.6: Examples of cardiac regions. (a) contrast-enhanced CT heart region; (b) LDCT heart 
region; (c) standard-dose gated CT scan coronary artery (red arrow); (d) LDCT coronary artery 
(red arrow). 
Although the high noise level and heart motion artifacts associated with LDCT impact 
the precision of image biomarker measurement, it has already been shown that cardiac 
biomarkers detected from LDCT such as CAC content are clinically useful. Shemesh et al. 
(2006) [20] have shown that CAC score derived from ungated LDCT can contribute to risk 
stratification and management of coronary artery disease. Shemesh et al. (2010) [21] have also 
shown that visual assessment of CAC on LDCT scans provides clinically relevant quantitative 
information as to cardiovascular death. LDCT related fully-automated cardiac algorithms have 
been developed by Isgum et al. (2009, 2012) [22-23]. In their work, the aorta and heart region 
were segmented using a multi atlas-based registration approach and the CAC was detected using 
a probability map and image feature-based classification. 
1.2.2    CAD in the lung region 
 There are a variety of CAD related studies concerning lung health diagnostics including 
the detection and characterization of pulmonary nodules and lung parenchymal diseases. In this 
section, only studies related to this dissertation are reviewed. They are: 
1) the characterization of small pulmonary nodules; 
2) the detection and characterization of early-stage ILD; 
3) the detection and characterization of early-stage pleural thickening. 
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1) Characterization of small pulmonary nodules 
In this dissertation, an algorithm has been developed to characterize small pulmonary 
nodule malignancy status and to evaluate the impact of nodule size distribution on 
characterization outcome. A large dataset with a total of 736 LCS nodules is used for training 
and evaluation in this study (size range 3 to 30 mm). A subset of size-balanced nodules is 
constructed which contains 163 malignant and 163 benign nodules of the same size distribution 
(size-range 5 to 14 mm). This subset is used to evaluate the impact of nodule size distribution as 
well as to explore the optimal training strategies when evaluating on a size-balanced nodule 
dataset. 
Most previous studies on nodule characterization by other research groups involve 
clinically detected nodules such as Shah et al. (2005) [24] (35 nodules, diameter ranged from 6 to 
54 mm with a mean of 25 mm) and Way et al. (2006) [25] (96 nodules, longest diameter ranged 
from 3.9 to 59.8 mm with a mean of 17.3 mm). These nodules are not very relevant in the 
context of LCS because the maximum nodule diameter should not exceed 30 mm in LCS [26]. A 
small number of studies used nodules from LCS (Suzuki et al. 2005, Aoyama et al. 2003, Armato 
et al. 2003) [27-29]. These three studies have all used the same dataset with more than 400 
benign nodules and less than 80 malignant nodules. Nodule size distribution was not taken into 
consideration in these three studies and the benign nodules were smaller in size than the 
malignant ones. 
Pulmonary nodule size is an important indicator for nodule malignancy. Our group’s 
previous work has indicated that ignoring nodule size could lead to overly-optimistic 
characterization result (Artit et al. 2007) [30]. In medical studies, Wisnivesky et al. (2004) [31] 
have reported that for stage I non-small cell lung cancers, the most curable cancers are below 15 
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mm in diameter and the larger they were, the less curable they became. A similar observation 
was made by McWilliams et al. (2013) [32]. They have found that the median size of the benign 
nodules was 3 to 3.4 mm while that of the malignant nodules was 12.8 to 13 mm in a LCS study. 
Because larger nodule is more likely to be malignant, in this dissertation a subset of malignant 
and benign nodules of the same size range (size-balanced nodules) has been constructed to 
evaluate their image feature difference independent of size. This is the first time a nodule 
characterization study has been performed on a large size-balanced dataset consisting of nodules 
less than 15 mm, the most relevant size range for LCS. 
2) Characterization of early-stage ILD 
 ILD is a group of lung parenchymal diseases characterized by progressive scarring of the 
lung tissue [33]. Some types of ILDs have known causes such as the exposure to allergens while 
others have unknown causes (idiopathic). ILD is generally irreversible and therefore it is 
important to detect ILD in its early stages. 
In this dissertation, a fully-automated algorithm has been designed to capture early-stage 
ILD from LDCT scans. In early-stage ILD, the abnormal tissue patterns are relatively localized 
and do not exhibit very distinguishable texture patterns. Figure 1.7 shows a normal CT scan 
together with an early-stage ILD scan. Rather than relying on complex texture features, the 
algorithm partitions the lung region into equal volume subsections and extracts a classic high-
density feature from each subsection to characterize the spatial distribution of parenchyma 
fibrosis. This feature vector is computed for both ILD cases and normal cases and is used for the 
classification of ILD versus normal CT scans. 
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                         (a)                                                          (b) 
Figure 1.7: Example CT scans comparing normal and early-stage ILD cases. (a) a normal case; 
(b) an early-stage ILD case (red arrows point to the lung fibrosis regions). 
In other previous studies, image patches were manually cropped from lung regions and 
image feature based classification was performed on these image patches. Depeursinge et al. 
(2012) [34] classified lung parenchymal patches into normal, emphysema, ground glass, fibrosis, 
and micronodules using wavelet related features. Xu et al. (2006) [35] calculated volumetric 
features including statistical, histogram, and fractal features from manually drawn volumes of 
interest in the lung parenchyma and classified the volumes into emphysema, ground-glass, 
honeycombing, normal nonsmokers, and normal smokers using these volumetric features. 
Korfiatis et al. (2010) [36] classified manually defined volumes of interest in the lung 
parenchyma into normal, ground glass, and reticular patterns using 3D co-occurrence features. 
The algorithm developed in this dissertation is distinctive from other research studies 
(Depeursinge et al. 2012, Xu et al. 2006, Korfiatis et al. 2010) [34-356] in two major aspects. 
First, the characterization target is the entire CT scan not lung parenchymal image patches. 
Second, it does not rely on complicated feature designs since the fibrosis is still early-stage and 
does not form unique texture patterns. Instead, it focuses on the detection of the unique spatial 
distribution of lung fibrosis through spatially partitioning the lung regions. 
3) Characterization of early-stage pleural thickening 
 Pleural thickening is the fibrosis of the visceral pleura. It is a lung disease associated with 
asbestos exposure (Gevenois et al. 1998) [37]. Conventionally, visual assessment is applied to 
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advanced pleural thickening such as those observed in patients with malignant pleural 
mesothelioma. In this dissertation, the target disease is early-stage pleural thickening as shown in 
Figure 1.8. It is much more subtle than advanced stage pleural thickening and should be 
characterized using different, more sensitive, methods. 
 
Figure 1.8: Example CT scan showing an early-stage pleural thickening case. Red lines outline 
the abnormal pleural surface region.  
In this dissertation, two different fully-automated pleural thickening characterization 
methods are presented to address the different manifestations of pleural thickening. The first 
method captures the subtler pleural thickening by computing the distance between pleural 
surface and ribs. This distance is used as a surrogate for the actual pleural thickness and it is 
hypothesized that for an early-stage pleural thickening case, this distance will be larger than that 
of a normal case. This method is designed to measure the pleural thickening regions not easily 
detectable visually. The second method captures the more conventional and visually detectable 
pleural thickening regions by detecting the concavities on the costal pleural surface. The volume 
of the concavities represents the pleural thickening severity of a given case. 
In other previous studies, pleural thickening is usually detected through two steps. First 
the abnormal regions on the lung surface are extracted often based on shapes. Then image feature 
classification is used to classify the extracted regions into pleural thickening and others. For 
instance, Sensakovic et al. (2011) [38] used a semi-automated method to segment the lung 
parenchyma pleural space. Then a classifier was used to identify malignant pleural mesothelioma 
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in the pleural space. Rudrapatna et al. (2005) [39] extracted pleural thickening candidates and 
computed pixel-based features to classify candidate pixels into pleural plaque or not plaque. 
Chaisaowong et al. (2014) [40] delineated pleural contours and obtained the pleural thickening 
regions using 3D tissue features. However, the automated studies were evaluated on relatively 
small datasets (140 image slices for Rudrapatna et al. [39] and 27 image slices for Chaisaowong 
et al. [40]) and their robustness on larger datasets is unknown. 
1.2.3    CT image quality assessment 
 The automated assessment of CT image quality is a necessary first step to ensure CT 
images are acceptable to be used in visual and automated analysis. CT image quality such as 
noise and calibration level is especially important to automated CAD algorithms since these 
algorithms are developed based on the assumptions that the images are well calibrated and have 
an acceptable noise level. For example, a CAD algorithm developed for images with a moderate 
noise level may not translate well to images with very high noise levels. 
 In this dissertation, a fully-automated method, which has been developed to measure CT 
image quality including noise and calibration values from 3D homogeneous regions in chest CT, 
is presented. This algorithm evaluates three 3D homogeneous regions: an external air region 
(EA), a trachea lumen region (TA) and a DA lumen blood region (AB) (see Figure 1.9). All 
measurement regions are automatically computed from existing segmentations and are in 3D 
space. The EA region spans through the extent of the whole lungs; the TA region starts from the 
top of the lungs and extends to the airway carina; the AB region starts at the airway carina and 
extends until the end of the segmented DA. The global noise and calibration values are measured 
in each homogeneous region. In addition, a per-slice quality profile is also computed for each 
region, i.e. the calibration and noise are measured for each axial slice to form a per-slice quality 
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profile spanning the whole lung region. This quality measurement method is validated on large 
datasets with various imaging parameters to demonstrate its repeatability and sensitivity. 
           
                                   (a)                                                     (b)                                  (c) 
Figure 1.9: Automatically extracted homogeneous regions for image quality measurement. (a) 
external air region (red); (b) airway lumen (green); (c) aorta lumen (blue). 
Previous studies measuring CT image quality have all used manually defined 2D circular 
image regions. Singh et al. (2011) [41] used manually drawn circular Region of Interests (ROIs) 
inside DA to measure image noise and calibration values. Ohno et al. (2012) [42] placed 
manually drawn circular ROIs inside trachea lumen, lung parenchyma, aorta, heart and other 
homogeneous regions for noise measurement. Yamada et al. (2012) [43] drew circular ROIs in 
the trachea, the pectoralis major muscle and the aorta to compute signal to noise ratio. In 
contrast, the method in this dissertation does not require manual markings and is able to 
characterize both the global image quality and the quality spatial variations. It should be noted 
that the quality assessment method presented in this dissertation measures image quality from the 
reconstructed CT images retrospectively and is therefore fundamentally different from the dose 
modulation method used clinically to minimize radiation dose while maintaining acceptable 
image quality [2, 44]. 
1.3    Segmentation using the Anatomy Label Map 
 The previous sections have given an overview of the main algorithms that are presented 
in the subsequent chapters. All these algorithms share a common characteristic: they utilize the 
pre-segmentation of other organs. For instance, the cardiac segmentation relies on the segmented 
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fat tissues, lung regions and bone structures. The ILD characterization uses the pre-segmented 
lung regions and the pleural thickening detection uses both the segmented lungs and labeled ribs. 
These pre-segmentations are performed using algorithms previously developed by our research 
group. These pre-segmented organs and regions include: the airway tree with labeled trachea and 
main bronchi (Lee et al. 2009) [45], the left and right lungs (Kostis et al. 2003) [46], skin surface 
and fat tissue (Padgett et al. 2014) [47], labeled individual ribs (Lee et al. 2010) [48] and other 
bone structures such as the sternum (Liu et al. 2015) [49] and the vertebra (Liu et al. 2016) [50]. 
In this subsection, a general overview of the segmentation framework and the pre-segmented 
regions is given. 
In our segmentation system, a top-down strategy is used where segmentation starts from 
the most robust and simplest regions. Then subsequent segmentations take advantage of the 
previously segmented regions (Reeves et al. 2017) [51]. The dependency relationship used in the 
sequential segmentations is shown in Figure 1.10. 
 
Figure 1.10: Dependency relationship between regions in the sequential segmentations. 
 The airway tree is segmented using a cylinder tracking and 3D region growing based 
method (Lee et al. 2009) [45]. In the segmented airway tree, the trachea and main bronchi are 
labeled. The trachea branching point is determined to be the carina. The colored airway tree 
segmentation is shown in Figure 1.11 (a). 
 The left and right lungs are segmented using image filtering, intensity thresholding and 
morphological operations (Kostis et al. 2003) [46]. The left and right lungs are partitioned with a 
minimum distance path-cutting algorithm. The colored two lungs are shown in Figure 1.11 (b). 
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 The skin surface is segmented by differentiating body from the outside air region. Fat is 
segmented using a local noise-aware algorithm (Padgett et al. 2014) [47]. The segmented skin 
and fat regions are shown in Figure 1.11 (c). 
 The individual ribs are segmented by employing an algorithm based on region growing 
and cylinder tracking (Lee et al. 2010) [48]. The labeled individual ribs are shown in different 
colors in Figure 1.11 (d). 
 
Figure 1.11: Visualization of existing segmentations in the ALM. (a) segmented airway tree with 
trachea (red) and bronchi (green); (b) segmented left and right lungs in different shades of pink; 
(c) segmented skin surface (magenta) and fat (yellow); (d) segmented and labeled individual ribs 
in different colors. 
Once a region is segmented, the segmentation result will be recorded into an Anatomy 
Label Map (ALM). The ALM is of the same size as the CT image and pixels corresponding to 
the segmented regions are labeled based on the region they are associated with. For example, in 
Figure 1.12, one axial slice of the ALM is shown together with the intensity image and each 
different label in the ALM is shown in a different color: fat pixels in yellow, left lung and right 
lung in two different shades of pink, ribs in multiple colors, skin surface in magenta, aorta in 
dark red, heart region in bright red.  
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                           (a)                                                        (b) 
Figure 1.12: Example slice in an ALM together with its intensity CT image. (a) intensity CT; (b) 
ALM where each label is shown in a unique color. 
Based on the dependency relationship in Figure 1.10, a later segmentation is not allowed 
to overwrite an earlier segmentation. For instance, lung segmentation is not allowed to include 
pixels already labeled as airway and cardiac segmentation is not allowed to include pixels 
already labeled as bone. The use of ALM and the sequential segmentation mechanism ensures 
that the more complex segmentations are built upon robust foundations. 
1.4    Overview 
 The following sections are organized as follows: Chapter 2 presents the cardiac organ 
segmentation and biomarker measurement algorithms, which includes the segmentation of aorta, 
PT, the general heart region and the segmentation of CAC, AC and cardiac visceral fat. 
Measurement of calcification content, aorta and PT diameters is also described. Chapter 3 
presents the lung region analysis which includes the characterization of pulmonary nodule, the 
detection and characterization of early-stage ILD and early-stage pleural thickening. Chapter 4 
presents an automated algorithm to assess CT image quality (noise and calibration) from 
homogeneous regions. Chapter 5 presents the conclusion.
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CHAPTER 2 
 
CARDIAC SEGMENTATION AND DISEASE BIOMARKER MEASUREMENT 
 Heart disease is the leading cause of deaths for both men and women. In the US, about 
610,000 people die from heart diseases every year [4]. Among all heart diseases, coronary heart 
disease is the most common type, killing about 365,000 people in 2014 [4]. Key risk factors for 
heart diseases include high blood pressure, high cholesterol, and smoking. Therefore, the 
subjects enrolled in lung cancer screening (aged 55-80 with a history of smoking [2]) are 
typically also at high risk of heart diseases. Evaluating heart disease risk factors on lung cancer 
screening CT scans offers additional benefit without exposing the subject to additional radiation. 
 In order to evaluate an individual’s heart disease risk factor, the cardiac organs are 
segmented and disease related biomarkers are measured. In the cardiac region, aorta is very well-
defined: it originates from the heart and extends through the thoracic region; it also has a 
cylindrical shape and a relatively clear boundary. Therefore, cardiac segmentation starts from the 
aorta, based on which other cardiac regions are obtained. 
The most important cardiac biomarker is the amount of CAC, an indicator of coronary 
heart diseases. This biomarker is obtained and measured using the spatial constraints provided by 
other segmented regions. Other biomarkers such as the aorta diameter profile and cardiac fat 
content are also measured. The following subsections are arranged as follows: 
1) Section 2.1 describes the cardiac organ segmentation algorithms: aorta in section 2.1.1, 
pulmonary artery trunk in section 2.1.2, and heart region in section 2.1.3; 
2) Section 2.2 describes the cardiac biomarker segmentation and measurement algorithms: CAC 
in section 2.2.1, aorta and PT diameter in section 2.2.2, AC in section 2.2.3, and cardiac visceral 
fat in section 2.2.4; 
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3) Section 2.3 presents the quantitative and qualitative evaluation methods: section 2.3.1 
describes the manual marking procedures and quantitative evaluation experiments; section 2.3.2 
describes the qualitative evaluation experiments; 
4) Section 2.4 presents the results for both quantitative (section 2.4.1) and qualitative (section 
2.4.2) evaluations; 
5) Section 2.5 and 2.6 are the discussions and conclusions. 
2.1    Segmentation of the aorta, the pulmonary artery trunk and the heart region 
 In this algorithm, first the aorta is segmented using a three-stage approach. Then the PT 
region is located using constraints from the ascending aorta (AA) segmentation. Finally, the 
general heart region is segmented based on constraints from the segmented aorta, the PT, as well 
as other anatomical structures. All segmentations utilize constraints from the ALM, which 
contains pre-segmented organs including the major airways, the lungs, ribs, and fatty tissues. The 
segmentation algorithm details for each of these three regions are described in the following 
subsections. 
2.1.1    Segmentation of the aorta 
 A novel three-stage algorithm (Xie et al. 2014) [52] is used to segment the aorta. In the 
first stage a seed point central to the aortic lumen is identified by circle fitting in the axial image 
slice at the level of the carina. Then a cylinder tracking algorithm is used to track the 
approximate aorta centerline upward and downward starting from the seed point. Finally, a 
surface refinement method is used to obtain the final aorta surface. The details of each of these 
stages are given in Algorithm 2.1 to Algorithm 2.3. Seed point detection is illustrated in Figure 
2.1. Figure 2.1 (a) shows the axial image slice at the level of the carina. Figure 2.1 (b) and (c) 
show the ALM for that image slice as well as the detected seed point (center of circle). Figure 
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2.2-2.3 show the model and details of the cylinder tracking stage and Figures 2.4-2.5 show the 
surface refinement stage. 
           
                      (a)                                                (b)                                            (c) 
Figure 2.1: Aorta seed point detection. (a) intensity CT image at the level of the carina; (b) ALM 
with pre-segmented organs in different colors; (c) an enlarged view of (b). Each color 
corresponds to a label: lungs (pink), fat (yellow), skin (magenta), airway carina (sea green), ribs 
(multi-color), vertebra and other bones (light green). The red circle (indicated by the arrow) is 
the largest circle fit into the unlabeled region. 
 
Algorithm 2.1 Aorta seed point location 
1) Select the axial label map at the level of the carina Mc (see Figure 2.1 (b)); 
2) Identify a ROI Is in Mc adjacent to the segmented vertebra Ivert and the segmented left lung 
Illung. Obtain the unlabeled region Ie, where 𝐼" = 𝐼$ ∩ 𝐼&"'( ∩ 𝐼))*+,                                                                                                      (2.1) 
3) Denote a circle C as (sx, sy, rc) where (sx, sy) is the center of C and rc is its radius. Find the 
largest C: argmax($3,$5) 𝑟8 = {(𝑠;, 𝑠<)|𝐶 = 𝑠;, 𝑠<, 𝑟8 ∈ 𝐼"}                                                                    (2.2) 
The corresponding (sx, sy) is the seed point (see Figure 2.1 (b)-(c)); 
 
 
           
          (a)                                       (b)                                                    
Figure 2.2: Aorta cylinder tracking model. (a) an aorta divided into ascending (AA in red), arch 
(Arch in green) and descending (DA in blue) sections; (b) upward and downward tracking 
model. 
  23 
 
Figure 2.3: Generation of cylinders with parameters in the aorta cylinder tracking stage. 
 
Algorithm 2.2 Cylinder tracking algorithm 
1) From the seed point (sx, sy), successively fit cylinders into the unlabeled region upwards 
and downwards (see Figure 2.2). Each cylinder Cyl is denoted by its length h, angle 
orientation (a, b) and radii r. The set of cylinders in the first iteration is Cyl0, where 𝐶𝑦𝑙C = {(ℎC, 𝑟C, 𝛼C, 𝛽C)|𝛼C ∈ 𝛼, 𝛽C ∈ 𝛽}                                                                         (2.3) 
2) Denote the number of unlabeled pixels in Cyl0 as M1 and the number of labeled pixels in 
Cyl0 as M2. Compute a matching score function: 𝑆C = 𝑀I − 𝜔 ∗ 𝑀M                                                                                                            (2.4) 
where w is the weight coefficient. Select the cylinder Cyl0M with the maximum score as the 
best matching cylinder: argmaxN<)OP 𝑆C = 𝐶𝑦𝑙CQ = (ℎCQ, 𝑟CQ, 𝛼CQ, 𝛽CQ |ℎCQ = ℎC, 𝑟CQ = 𝑟C, 𝛼CQ ∈ 𝛼, 𝛽CQ ∈ 𝛽}(2.5) 
3) Starting from the next generation i (i ³ 1), a series of cylinders Cyli are generated. Cyli 
progress for a length of Dstep compared to the Cyl(i-1)M. Cyli is parameterized as follows: 𝐶𝑦𝑙R = {(ℎR, 𝑟R, 𝛼R, 𝛽R)|ℎR = ℎC, 𝑟R ∈ 𝑐I𝑟 RTI Q, 𝑐M𝑟 RTI Q , 𝛼R ∈ 𝛼, 𝛽R ∈ 𝛽}                   (2.6) 
      The same procedure is used to select CyliM (see Figure 2.3); 
4) Terminate tracking at iteration i where 
      	𝑖 = {𝑟RQ > 𝑐X𝑟YQ ∪ 𝑟RQ < 𝑐\𝑟YQ|𝑘 ∈ [𝑖 − 10, 𝑖 − 1]}                                                   (2.7) 
 
 
 
 
                (a)                                                         (b)                                                       (c) 
Figure 2.4: Aorta surface refinement. (a) a section of the triangular mesh model with unit 
diameter; (b) centerline Pi, center points xi and the perpendicular image rays Ri; (c) the detected 
aorta surface represented by the triangular mesh. 
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                        (a)                                              (b)                                      (c) 
Figure 2.5: Ray averaging model and final segmentation. (a) ray averaging model; (b) final 
segmented aorta (red) overlaid on the intensity image in an axial slice; (c) final segmented aorta 
(red) together with lungs (pink) and bones (light grey) in a sagittal view. 
 
Algorithm 2.3 Ray casting algorithm 
1) Denote the center points of the best matching cylinders as P={P0, P1, …PN}. Partition P 
into k continuous subsets with approximately the same size. In each subset, fit a 3rd order 
polynomial function to the points to form a polynomial centerline CLi; 
2) Map a triangular mesh model with unit diameter to CLi, iÎ[1, 2,…, k]. The mesh model 
interval between layers is L mm (see Figure 2.4 (a)); 
3) Cast image rays perpendicular to CLi through the center of each triangle (see Figure 2.4 
(b)). Denote each ray as R and the sampled intensity values along R as r1, r2, …, rt. Denote 
the 12 neighboring rays of R as N1 to N12 and the sampled intensity along Ni as r1Ni, r2Ni, 
…, rtNi, compute the averaged intensity for R (see Figure 2.5 (a)): 𝑟R = 'bc 'bdeefghefgIX                                                                                                                (2.8) 
4) Based on the averaged values, determine a termination location for each R based on a pre-
set fat tissue threshold Tf, where argminR 𝑖 = {𝑟R < 𝑇l|𝑖 ∈ [1, … , 𝑡]}                                                                                   (2.9) 
5) If no such termination location can be found, terminate R when it first intersects with the a 
labeled pixel. 
6) Together the termination points are used to construct the final aorta surface (see Figure 2.5 
(b)-(c)). 
 
 
Aorta segmentation parameters are listed in Table 2.1. Parameters used in cylinder 
tracking are crucial to the segmentation success. Several aspects are taken into considerations 
when designing the tracking parameters: 
1) Tracking parameters should be relaxed enough so that tracking does not terminate too early, 
i.e. a small percentage of labeled pixels should be allowed in the cylinder regions and a small 
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diameter variation should be allowed; 
2) Ascending tracking parameters should be relaxed enough so that the cylinders can go around 
the curved aortic arch; 
3) Tracking parameters should be strict enough so that the model cylinders do not turn into other 
unlabeled regions outside aorta; 
Table 2.1. Aorta segmentation parameters. 
Parameter Meaning Value 
h0 Model cylinder height 20mm 
r0 Initial cylinder radii range [8mm, 30mm] 
a Cylinder azimuthal angle [0, 0.2p] for descending; 
[0, 0.25p] for ascending; 
b Cylinder polar angle [0, 2p] 
w Coefficient in the matching score function 30 
c1 and c2 Radii change percentage c1=0.5 and c2=1.5 for ascending; 
c1=0.8 and c2=1.2 for descending; 
c3 and c4 Radii change percentage upper and lower 
limits 
c3=2 and c4=0.5 
Dstep Cylinder progression length 4mm 
L Ring interval in the triangular mesh model 4mm 
Tf High threshold for fat pixels  -30HU 
   
2.1.2    Segmentation of the pulmonary artery trunk 
 Pulmonary artery carries deoxygenated blood from the heart to the lungs. It originates 
from the right ventricle and has an almost vertical section (PT) before branching into the two 
lungs (see Figure 2.6 (a) [53]). An enlarged pulmonary artery diameter is associated with 
pulmonary hypertension (Edwards et al. 1998, Devaraj et al. 2010) [54-55]. Conventional 
measurement of pulmonary artery diameter is usually performed manually on the main 
pulmonary artery at the level of bifurcation (see Figure 2.6 (b)). However, in low-dose non-
contrast CT, pulmonary artery in this region does not usually have a well-defined shape or 
boundary and is difficult to be robustly segmented. 
 An alternative segmentation and measurement is used in this study: the pulmonary artery 
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trunk region (see Figure 2.6 (a), (c)) adjacent to the AA is segmented and measured instead of 
the main pulmonary artery. Compared to main pulmonary artery, this region is better defined and 
constrained by aorta and fatty tissues and can be more robustly segmented. 
     
                      (a)                                         (b)                                           (c)                
Figure 2.6: Example images of pulmonary artery. (a) a diagram showing the pulmonary artery 
with the red arrow pointing to PT; (b) the conventional manual measurement of main pulmonary 
artery diameter; (c) proposed segmentation of PT adjacent to the AA. 
 The PT segmentation algorithm (Xie et al. 2015) [56] is listed in Algorithm 2.4. It is 
performed in the unlabeled region adjacent to the AA. First the segmented AA is extended to 
ensure that it covers the whole PT region; then PT approximate centerline is determined; finally, 
a similar ray casting with triangular mesh model is used to detect its surface. 
 
Algorithm 2.4 Pulmonary artery trunk segmentation 
1) Extend the segmented AA in a slice-by-slice fashion by projecting it downwards into the 
unlabeled circular region. In each slice i, denote the unlabeled region as Ri and the major 
and minor axis of Ri as Ri1 and Ri2, terminate projection in slice i where, argminR 𝑖 = {𝑅RM < 0.8 ∗ 𝑅RI}                                                                                         (2.10) 
2) Obtain the new aorta centerline from the projection and re-compute aorta surface as AAnew 
(see Figure 2.7); 
3) Detect PT seed point Spt axially at the level of AAnew by using a fixed-sized circle of radius 
s0 in the unlabeled region adjacent to AAnew. This circle Cmin has a minimized distance to 
the left and anterior boundaries and Spt is the center of Cmin (see Figure 2.8 (a)-(b)); 
4) Use the same triangular mesh and ray casting method described in Algorithm 2.3 to obtain 
PT surface location (see Figure 2.8 (c)-(d)). 
 
 
 The circle Cmin has a radius s0 of 10mm. Compared to aorta segmentation, PT 
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segmentation is simpler since it is a relatively small region well-bounded by the aorta, the lung 
and the fat tissues. 
           
                                   (a)                                                                            (b) 
Figure 2.7: Two different cases before and after applying AA extension. For each pair of images, 
left is before and right is after applying the modification. 
                     
          (a)                      (b)                            (c)                         (d) 
Figure 2.8: Examples images showing (a)-(b) seed point detection and (c)-(d) final segmentation 
of PT in two cases. In (a) and (b), aorta is in red and seed point circle is in blue with the red 
arrows indicating the seed points; in (c) and (d) DA is in red, AA is in light blue and PT is in 
blue. Other segmented organs such as lungs, fat and vertebrae are also colored. 
2.1.3    Segmentation of the heart region 
 Segmentation of the heart region establishes an important landmark for the segmentation 
of CAC, one of the most important cardiac biomarkers. However, in LDCT the exact heart 
boundary is generally not detectable due to the high level of image noise and the lack of contrast 
(see Figure 2.9). There is only strong evidence for the general heart region, i.e. the thoracic 
region inferior to the aorta, superior to the abdomen, bounded by the two lungs and fatty tissues. 
Therefore, the heart region is defined by the constraints from adjacent pre-segmented organs. 
Heart region segmentation (Xie et al. 2014) [57] algorithm is described in Algorithm 2.5. 
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                      (a)                                           (b)                                     (c) 
Figure 2.9: Heart region defined by constraints. (a) intensity CT image; (b) heart region (green) 
constrained by aorta (red), fat (yellow) and lungs (pink); (c) heart region (green) in sagittal view 
constrained by aorta (red) and PT (blue). 
 
Algorithm 2.5 Heart region segmentation 
1) Obtain heart region left and right boundaries HrtL and HrtR using the segmented lungs; 
2) Obtain heart region anterior boundary HrtA using segmented fat tissues and sternum; 
3) Obtain heart region posterior boundary HrtP using the DA; 
4) Use AA and DA to define the vertical extent of the heart region HrtS and HrtI; 
5) Determine a unlabeled region I. Denote the left, right, anterior, posterior, superior, and 
inferior boundaries of I as IL, IR, IA, IP, IS, II, I is determined as: 𝐼 = {𝐼r > 𝐻𝑟𝑡r ∩ 𝐼t < 𝐻𝑟𝑡t ∩ 𝐼u < 𝐻𝑟𝑡u ∩ 𝐼v > 𝐻𝑟𝑡v ∩ 𝐼w < 𝐻𝑟𝑡w ∩ 𝐼x > 𝐻𝑟𝑡x}    (2.11) 
6) Perform connected-component analysis on I to obtain connected regions Icc1, Icc2, …, Icck. 
Select the largest Icci as the heart region (see Figure 2.9). 
 
 
2.2    Segmentation and measurement of cardiac biomarkers 
 Based on the cardiac segmentation, related image biomarkers are measured. In this 
section, 5 different biomarkers are segmented and/or measured: section 2.2.1-section 2.2.4 
correspond to the following biomarkers: CAC content, aorta and PT diameter, AC content, and 
cardiac fat content. While some of the biomarkers can be easily obtained through intensity 
thresholding in a mask region, others such as the CAC content require more complex spatial 
modelling. 
2.2.1    Segmentation and measurement of CAC 
 CAC is one of the most important biomarkers in the cardiac region. It is an indicator of 
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coronary heart disease, the most common type of heart disease [4]. In this work, the analysis of 
CAC consists of two goals: the fully-automated segmentation of all CAC, and the labeling of 
CAC based on arteries. 
 Coronary arteries are located at the heart surface (see Figure 2.10 (a)-(b) [58]). There are 
four main arteries: Left Main Artery (LM, sometimes also named left coronary artery), Left 
Anterior Descending (LAD), Left Circumflex (LCX), and Right Coronary Artery (RCA). 
However, in LDCT they are usually not distinguishable from heart muscles unless they are 
calcified (see Figure 2.10 (c)-(d)). Therefore, the segmentation of CAC relies on the geometric 
modeling of calcified regions rather than the explicit segmentation of coronary arteries. Figure 
2.11 shows example CACs in different arteries. The CAC segmentation algorithm is described in 
Algorithm 2.6. 
 Labeling of CAC by artery location provides the opportunity to evaluate the CAC content 
in each individual artery. Tota-Maharaj et al. (2015) [59] demonstrated that LM and LAD CAC 
had independent prognostic significance in predicting mortality by manually labeling and scoring 
CAC content by the 4 main artery groups (LM, LAD, LCX, RCA). In this dissertation, the 
automated labeling combined LM and LAD CAC into one label due to the difficulty to visually 
distinguish them at the border, which is similar to other automated CAC labeling algorithms such 
as that by Wolterink et al. (2015) [19] and Ding et al. (2015) [60]. The algorithm produces 3 
labels: LM+LAD CAC, LCX CAC, RCA CAC. The labeling algorithm is listed in Algorithm 2.7 
(Xie et al. 2017) [61]. 
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                    (a)                                (b)                            (c)                                (d) 
Figure 2.10: Diagrams and examples of coronary arteries. (a) diagram of the four main coronary 
arteries within the heart; (b) simplified diagram depicting the geometric locations of the coronary 
arteries relative to the heart, AA and PT; (c) a case where the coronary artery is visible because 
of CAC; (d) a case where the coronary artery is indistinguishable due to the lack of CAC. 
           
                (a)                                       (b)                                         (c) 
Figure 2.11: Example CACs in different arteries. (a) LM+LAD CAC (red arrow); (b) LAD CAC 
(red arrow) and LCX CAC (purple arrow); (c) RCA CAC (blue arrow). 
 
 
Algorithm 2.6 Segmentation of CAC 
1) Pre-filter the intensity CT image I with filter Sf. The size of Sf varies based on the heart 
region noise level HrtN (pixel standard deviation). Denote the filtered image as If; 𝐼l = 𝐼⨂𝑆l                                                                                                                       (2.12) 
2) Denote the segmented heart region as Hrts, dilate it to HrtD with a kernel kD to include all 
the potential CAC candidates; 𝐻𝑟𝑡z = 𝐻𝑟𝑡$⨁𝑘z                                                                                                          (2.13) 
3) Threshold If in HrtD at Tc to obtain all CAC candidates Icac1. Denote a pixel in If as Ip, 𝐼8|8I = {𝐼} ≥ 𝑇8|𝐼} ∈ 𝐻𝑟𝑡z}                                                                                          (2.14) 
4) Exclude Ip on the surface of aorta (AC, see Figure 2.12 (a)) or adjacent to AA root (aortic 
valve calcification, see Figure 2.12 (c)); 
5) Exclude candidates in the lung heart transition region (artifacts, see Figure 2.11 (b)) and 
candidates in the posterior central heart region (mitral valve calcification, see Figure 2.11 
(d)). 
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                 (a)                                     (b)                                 (c)                                  (d) 
Figure 2.12: Examples of excluded high-intensity regions. (a) AA calcification; (b) calcium and 
artifacts in lung-heart transition region; (c) aortic valve calcification; (d) mitral valve 
calcification. 
 The parameters in Algorithm 2.6 is listed in Table 2.2. In an ideal situation (low image 
noise), no filtering is needed and the standard calcification threshold of 130HU is sufficient. 
However, in LDCT scans, no filtering and standard threshold would result in noise pixels being 
mistaken as calcification. On the other hand, a larger filter window or higher threshold value 
may lead to the loss of small regions of calcification. Therefore, filter sizes and threshold values 
are designed to reduce the effect of noise while minimizing the loss of calcification. 
Table 2.2. CAC segmentation parameters. 
Parameter Meaning Value 
Sf Mean filter window size 3 pixels for HrtN<=150HU; 
5 pixels for HrtN>150HU; 
Tc Calcification threshold 130HU for superior heart; 
180HU for inferior heart; 
kD Dilation kernel size 30 mm 
 
CAC labeling relies on the spatial constraints from pre-segmented organs such as the 
aorta, heart region and pulmonary artery trunk. The general labeling model is shown in Figure 
2.12. Labeling starts from the most easily identified CAC regions (RCA and LM+LAD CAC) 
and use them as constraints for the more subtle CAC regions. The algorithm details are listed in 
Algorithm 2.7. 
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Figure 2.13: CAC labeling model. The four main arteries are shown together with the heart 
region, AA, and PT. 
 
Algorithm 2.7 Labeling of CAC 
1) Denote all CAC candidates as ICAC. Denote the segmented left and right lung as ILLung and 
IRLung. Denote the inferior AA margin as AAi and the inferior heart margin as Hrti. 
Segment RCA CAC IRCA by applying constraints (see Figure 2.14 (a)): 𝑅)R$( = 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝐼rr*+,, 𝐼} , 					𝐼} ∈ 𝐼NuN                                                                    (2.15) 𝑅'R$( = 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝐼tr*+,, 𝐼} , 					𝐼} ∈ 𝐼NuN                                                                   (2.16) 𝐼tNu = {𝑅)R$( > 𝜔t ∗ 𝑅'R$(|𝐼} ∈ 𝐼NuN, 𝐼} > 𝐴𝐴R ∩ 𝐼} < 𝐻𝑟𝑡R}                                   (2.17) 
where wR is a weight coefficient; 
2) Segment LM+LAD CAC adjacent to aorta ILMD1. Denote the relative location of ICAC to 
AA as AAang (shown in Figure 2.14 (d)). Denote the superior heart margin as Hrts. 𝑅|R$( = 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝐴𝐴, 𝐼} ,			𝐼} ∈ 𝐼NuN                                                                           (2.18) 𝐼rQzI = {𝑅)R$( < 𝜔r ∗ 𝑅'R$( ∩ 𝑅|R$( < 𝐴𝐴R$( ∩ 𝐴𝐴|+, = 4|𝐼} ∈ 𝐼NuN, 𝐼} < 𝐴𝐴R + 𝑑I ∩𝐼} > 𝐻𝑟𝑡$}                                                                                                             (2.19) 
where AAdist and d1 are distance margins and wL is a weight coefficient (see Figure 2.14 
(b)-(d)); 
3) Label remaining left CACs. If any ILMD1 is detected in step 2, the remaining CACs anterior 
to it is labeled as LM+LAD CAC and those posterior to it is labeled as LCX CAC; 
otherwise proceed to step 4 (see Figure 2.15 (a)); 
4) Label the left CACs adjacent to PT as ILMD2 and perform anterior/posterior partitions based 
on ILMD2 as shown in Figure 2.15 (b). If no ILMD2 is detected, label ILMD3 based on its 
location to AA and performs partitions using ILMD3 as shown in Figure 2.15 (c). 𝐼rQzM = {𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑃𝑇, 𝐼} < 𝑃𝑇R$(|𝐼} ∈ 𝐼NuN}                                                          (2.20) 𝐼rQzX = {𝐴𝐴|+, = 1|𝐼} ∈ 𝐼NuN}                                                                                    (2.21) 
 
  
The parameters used in CAC labeling is listed in Table 2.3. The parameters are designed 
to be general enough to accommodate for anatomical variations within the heart region. At the 
same time, they should also be strict enough to not mistake one region for another. 
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Table 2.3. CAC labeling parameters. 
Parameter Meaning Value 
wR weight coefficient for RCA CAC distance to the lungs 3 
AAang LM+LAD CAC location relative to AA 4 
AAdist Maximal distance between LM+LAD CAC and AA 30mm 
d1 Maximal distance between LM+LAD CAC and inferior aorta 15mm 
wL weight coefficient for LM+LAD CAC distance to the lungs 1 
PTdist Maximal distance between LM+LAD CAC and PT 40mm 
 
                
                (a)                                     (b)                                         (c)                               (d) 
Figure 2.14: Labeling of RCA CACs and LM+LAD CACs adjacent to aorta. (a) RCA CAC 
labeling; (b) and (c) show the labeling of LM+LAD CACs adjacent to aorta; (d) AA relative 
angle computation. 
 
           
                   (a)                                            (b)                                             (c) 
Figure 2.15: Labeling of remaining left region CACs. (a) partition model when there is 
calcification adjacent to AA; (b) partition model using CAC adjacent to PT; (c) partition model 
using the AA. 
2.2.2    Measurement of aorta diameter profile and PT diameter 
 Enlarged aorta diameter may be an indicator of aorta aneurysms and impending ruptures 
(Schwartz et al. 2007) [62], therefore making the early detection of abnormal aorta diameter very 
important. Pulmonary artery diameter has been traditionally measured in an axial slice at the 
bifurcation level to assess for pulmonary hypertension risk. Sometimes pulmonary artery 
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diameter to AA diameter ratio is measured as an alternative to pulmonary artery diameter 
(Edwards et al. 1998, Devaraj et al. 2010, Karazincir et el. 2008, Truong et al. 2012) [54-55, 63-
64]. In our study, both PT and AA equivalent diameters are measured. The aorta diameter profile 
is also computed. The measurement algorithm is summarized in Algorithm 2.8. 
 
Algorithm 2.8 Measurement of aorta and PT diameter 
1) Measure equivalent aorta diameter from triangular mesh model (see Algorithm 2.3). For 
each ring of triangles perpendicular to the centerline, denote its cross-sectional area as Ai. 
The equivalent diameter for each ring is denoted as di: 𝑑R = 2 ub                                                                                                                        (2.22) 
Starting from AA to DA, the equivalent diameter for each ring {d1, d2, …, dN} is the aorta 
diameter profile (see Figure 2.16 (a)); 
2) Obtain the set of equivalent diameters of the AA {dAA1, dAA2, …, dAAm} and compute its 
average: 𝑑uu = I 𝑑uuRRRI                                                                                                          (2.23) 
3) Similarly obtain the set of equivalent diameters in the PT triangular mesh model {dPT1, 
dPT2, …, dPTn} and compute its average: 𝑑v = I+ 𝑑vRR+RI                                                                                                           (2.24) 
4)  Compute the diameter ratio dR as shown in Figure 2.16 (b). 𝑑t =                                                                                                                          (2.25) 
 
 
      
                            (a)                                                (b) 
Figure 2.16: Aorta and PT diameter measurement. (a) aorta diameter profile from ascending to 
descending; (b) region where the diameters are measured (light and dark blue). Heart (green) and 
lungs (pink) are also shown. 
2.2.3    Segmentation and measurement of AC 
Thoracic AC is associated with an increased risk of cardiovascular disease and death 
(Eisen et al. 2008) [65]. It manifests in a CT image to be high-intensity calcium deposits on the 
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aorta surface (see Figure 2.17 (a)-(b)). Using the traditional Agatston scoring method (Agatston 
et al. 1990) [66] used for CAC scoring, AC tends to have a much higher Agatston score (AS) 
compared to CAC (see Figure 2.17 (c)-(e)). 
               
             (a)                        (b)                     (c)                (d)                 (e) 
Figure 2.17: Examples of AC. (a) calcification in AA and DA (red arrows); (b) aortic arch 
calcification (red arrows); (c)-(e) three cases with different levels of AC. The AS for (c), (d) and 
(e) is respectively 302, 3311 and 9088. 
 AC can be measured in the aorta mask region (Xie et al. 2014) [67] using the method 
listed in Algorithm 2.9. The algorithm is similar to that used for the CAC segmentation 
(Algorithm 2.6). Compared to CAC, AC is less likely to be confused with other calcification 
since it is only located on the surface of aorta. Therefore, a simpler method is used. The 
associated parameters are listed in Table 2.4. Similar to CAC segmentation parameters, the filter 
size and threshold value are selected to minimize the impact of noise while retaining the largest 
amount of detectable calcification. 
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Algorithm 2.9 Segmentation of AC 
1) Pre-filter the intensity CT image I with a filter of size SA to reduce the effect of noise; 𝐼l = 𝐼⨂𝑆u                                                                                                                       (2.26) 
2) Dilate the segmented aorta As with a kernel kD to AD to include all potential calcification; 𝐴z = 𝐴$⨁𝑘z                                                                                                                  (2.27) 
3) Extract high intensity candidates IAC1 in AD by thresholding at TA; 𝐼uNI = {𝐼} ≥ 𝑇u|𝐼} ∈ 𝐴z}                                                                                               (2.28) 
4) Perform connected component analysis and eliminate candidate smaller than VA pixels as 
noise regions. The refined candidates are denoted as IAC2: 𝐼uNM = {𝑣𝑜𝑙𝑢𝑚𝑒 𝐼} ≥ 𝑉u|𝐼} ∈ 𝐼uNI}                                                                            (2.29) 
5) Eliminate candidates adjacent to segmented bone and airway surface as bone or airway 
calcification or airway artifacts (see Figure 2.18 for exclusion examples). 
 
 
Table 2.4. AC segmentation parameters. 
Parameter Meaning Value 
SA Mean filter window size 3 pixels 
TA Calcification threshold 160HU 
VA Minimal calcification volume 5 pixels 
kD Dilation kernel size 5mm 
 
           
                       (a)                                                              (b) 
Figure 2.18: Exclusion of non-AC artifacts. (a) shows airway calcification (blue arrow); (b) 
shows bone pixels (blue arrow). All high-intensity regions are colored red. For each pair, left is 
before exclusion and right is after exclusion. 
2.2.4    Segmentation and measurement of cardiac visceral fat 
 Fat around the heart region is associated with cardiovascular diseases (Rosito et al. 2008) 
[68]. The most commonly measured cardiac fat is pericardial fat, i.e. fat enclosed by the visceral 
pericardium (see Figure 2.19 (a)-(b)). However, in LDCT the pericardium region is not always 
clearly visible (see Figure 2.19 (c)). Therefore, an alternative approach is adopted to measure all 
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the fat in the cardiac visceral region – cardiac visceral fat (CVF). It is defined to be at the same 
level of the segmented heart, enclosed by lungs and posterior to the sternum (see Figure 2.19 
(d)). 
 Similar to heart region segmentation, CVF segmentation relies on the constraints from 
adjacent pre-segmented organs. However, the anterior region needs further refinement to stop the 
CVF from leaking out of the sternum. The algorithm listed in Algorithm 2.10 is used to segment 
CVF (Xie et al. 2015) [69]. 
 
              (a)                           (b)                             (c)                             (d) 
Figure 2.19: Pericardial fat and CVF. (a) intensity CT image with red arrow pointing to the 
pericardium; (b) pericardial region (yellow outline) in (a); (c) intensity CT image without visible 
pericardium; (d) cardiac visceral region (yellow outline) in the same image as (a) and (b). 
 
Algorithm 2.10 Segmentation of cardiac visceral fat 
1) At the level of heart, constrain the CVF using the segmented lungs, sternum, DA or 
vertebrae (see Figure 2.19 (a)); 
2) Refine the fat region between sternum and lungs axially. In the anterior region, if the lungs 
form a closed boundary, eliminate all fat between sternum and lungs and proceed to step 5. 
Otherwise proceed to step 3; 
3) Draw a horizontal like yi defined by the sternum posterior margin. Shift yi towards 
posterior until it intersects with the lungs at yk. The intersection points are denoted as lk 
and rk and their distance dk: 𝑑Y = |𝑙Y − 𝑟Y|                                                                                                                 (2.30) 
4) Continue shift yk towards the posterior until it reaches yp: argmin< 𝑑} = {𝑑}|𝑑} = |𝑙} − 𝑟}|}                                                                                  (2.31) 
Together yk and yp define the anterior CVF region; 
5) Perform connected-component analysis to all the fat pixels in the constrained region. 
Retain the fat pixels connected to the heart region to eliminate other non-cardiac fat pixels 
(see Figure 2.20 (b)-(c)). 
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                (a)                               (b)                           (c)                                  (d) 
Figure 2.20: CVF segmentation. (a) model with the anterior refinement; (b) and (c) show the 
segmented CVF (yellow) together with the aorta (red) and the heart (green) in an axial slice and 
in sagittal view; (d) anterior refinement model where the red box indicates the modeled region 
between the sternum and lungs. 
2.3    Quantitative and qualitative evaluation methods 
 Cardiac region segmentation and biomarker measurements are evaluated quantitatively 
and qualitatively. Quantitative evaluation is performed on a set of CT scans with reference 
manual markings or semi-automatically measured reference biomarkers. Qualitative evaluation is 
performed through the visual inspection of segmentation outcomes. Both evaluation methods are 
described in detail in section 2.3.1 and 2.3.2. 
2.3.1    Quantitative evaluation experiments 
Tables 2.5-2.6 list the segmented regions and biomarkers used in the quantitative 
evaluation as well as the corresponding evaluation metrics, datasets and references. Definitions 
and justifications of these evaluation metrics are given in Evaluation 2.1 and 2.2. All CT scans 
used for evaluation are non-contrast chest CT scans. The majority of them are thin-slice (slice-
thickness <= 1.25mm) and low-dose and come from the two public datasets: VIA-ELCAP public 
dataset [70] and the LIDC public dataset [71]. Example reference regions for segmentation and 
image biomarkers are demonstrated in Figures 2.21-2.23. In general, quantitative evaluation is 
performed using standard comparison methods such as evaluating the agreement between 
automated and reference regions through the Dice Similarity Coefficient (DSC) or computing the 
Pearson correlation coefficient between automated and reference calcification scores. 
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The only quantitative evaluation based on visual scores rather than manual markings is 
the CAC categorical visual scores for each artery (see Table 2.6 CAC row and Figure 2.23). 
Each scan was assigned a categorical visual CAC score for each of the four main arteries (LM, 
LAD, LCX, RCA) by a radiologist using the criteria established by Shemesh et al. (2010) [21]. 
The score ranges from 0 to 3: 0=none, 1=mild, 2=moderate,3=extensive. In this evaluation, the 
visual scores of LM and LAD are added together for LM+LAD CAC assessment. For total CAC 
assessment, visual scores from the four arteries are added together. 
Table 2.5. Quantitative evaluation metrics for cardiac segmentation. 
Region Metric Reference Dataset 
Aorta DSC, Bpn, 
µd 
Manual aorta boundaries (ascending, 
descending, arch) 
630 boundaries from 60 
scans [70-71] 
PT DSC Manual boundary in a central slice in the 
segmented region 
45 boundaries from 45 
LDCT [70] 
CVF DSC Manual boundaries in 3 evenly spaced 
slices in the segmented region 
135 boundaries from 45 
LDCT [70] 
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Evaluation 2.1: Definition and justification for segmentation evaluation metrics 
1) Dice Similarity Coefficient (DSC):  𝐷𝑆𝐶 = 2 𝑅'"l ∩ 𝑅|*( /( 𝑅'"l + |𝑅|*(|)                                                                  (2.32) 
where Rref is the reference region and Rauto is the automatically segmented region. DSC is 
one of the classic and most common region segmentation evaluation metric. If the Rauto 
completely overlaps with Rref, DSC becomes 1; if there is no overlapping, DSC becomes 0. 
The higher DSC is, the more the two regions agree with each other; 
2) Bias term Bpn: 𝐵}+ = vTvv                                                                                                                  (2.33) 
where 𝑃l} = ∑𝐼}, 𝐼} ∈ 𝑅|*( ∩ 𝑅'"l                                                                                         (2.34) 𝑃l+ = 𝐼} , 𝐼} ∈ 𝑅|*( ∩ 𝑅'"l                                                                                       (2.35) 𝑃(} = Σ𝐼}	, 𝐼} ∈ 𝑅|*( ∩ 𝑅'"l                                                                                         (2.36) 
Bpn indicates whether the algorithm over-segments (Bpn>0) or under-segments (Bpn<0). It 
provides additional information to DSC since DSC does not distinguish between over- and 
under-segmentation; 
3) A boundary distance di is defined as d  = argminb { 𝑚𝑥R − 𝑎𝑥R M + 𝑚𝑦R − 𝑎𝑦R M + 𝑚𝑧R − 𝑎𝑧R M}                                 (2.37) 
where (mxi, myi, mzi) is a pixel in the boundary of Rref and (axj, ayj, azj) is a pixel in the 
boundary of Rauto. µd is the mean of all di. It is more sensitive than DSC and Bpn to small 
boundary changes. 
 
 
Table 2.6. Quantitative evaluation metrics for cardiac biomarker measurements. 
Biomarker Metric Reference Dataset 
CAC Pearson correlation coefficient 
(AS, Volume Score VS, Mass 
Score MS), confusion matrix (AS 
based risk category) 
Manual CAC 
regions 
41 LDCT (private 
cohort) 
CAC Spearman correlation coefficient 
(AS, VS, MS), labeling sensitivity 
and specificity (by artery and by 
noise level) 
Visual CAC scores 
by artery 
1,359 LDCT 
(private cohort) 
AC Pearson correlation coefficient 
(AS, VS, MS) 
Manual AC regions 45 LDCT [70]  
PT 
diameter 
Pearson correlation coefficient and 
Limits of Agreement (LOA) 
Manual pulmonary 
artery diameter at 
bifurcation 
45 LDCT [70] 
AA 
diameter 
Pearson correlation coefficient and 
LOA 
Manual AA diameter 
at bifurcation 
45 LDCT [70] 
PT/AA 
ratio 
Pearson correlation coefficient and 
LOA 
Manual diameter 
ratio 
45 LDCT [70] 
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Evaluation 2.2: Definition and justification for biomarker evaluation metrics 
1) Agatston-weighted score (AS): clinically defined calcification score. Denote a calcification 
area as CACi and its corresponding weight coefficient as wi. Denote the maximum 
intensity in CACi as pi. AS is defined as: 𝐴𝑆 = 𝜔R ∗ 𝐶𝐴𝐶R                                                                                                           (2.38) 
where 
𝜔R = 1, 𝑝R ∈ (−∞, 200𝐻𝑈)2, 𝑝R ∈ [200𝐻𝑈, 300𝐻𝑈)3, 𝑝R ∈ [300𝐻𝑈, 400𝐻𝑈)	4, 𝑝R ∈ [400𝐻𝑈,+∞)                                                                                   (2.39) 
2) Volume score (VS): total volume (mm3) of the calcification region; 
3) Mass score (MS): total volume with each pixel weighted by its HU intensity; 
4) Pearson correlation coefficient (Pearson R): ranges from -1 to 1 and characterizes the 
linear correlation between two continuous variables, where 1 indicates total positive 
correlation and -1 indicates total negative correlation; 
5) Spearman correlation coefficient (Spearman R): ranges from -1 to 1 and characterizes the 
rank correlation between two continuous or categorical variables; 
6) Limits of Agreement 95% (LOA): Bland-Altman 95% LOA [72]. It gives the degree of 
agreement between method X and method Y. Denote the mean and standard deviation of 
(X-Y) as µXY and sXY, LOA can be approximated as follows: 𝐿𝑂𝐴 = [𝜇ª« − 1.96 ∗ 𝜎ª«, 𝜇ª« + 1.96 ∗ 𝜎ª«]                                                               (2.40) 
7) Confusion matrix (CM): CM is used to compare the automated risk categories and manual 
risk categories, which are defined by the automated and manual Agatston scores AS. Risk 
category = 1 (AS<=10), 2 (ASÎ[11, 100]), 3 (ASÎ[101, 400]), and 4 (AS>400); CM 
clearly indicates the disagreement between the two risk categories between different risk 
levels; 
8) Sensitivity: defined by number of true positives TP (both automated and reference CAC 
scores > 0) and the number of false negatives FN (only reference CAC scores > 0). 
Sensitivity characterizes the algorithm’s ability to capture all the true CAC regions: 𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 = 𝑇𝑃/(𝑇𝑃 + 𝐹𝑁)                                                                                      (2.41) 
9) Specificity: defined by number of true negatives TN (both automated and reference CAC 
scores = 0) and the number of false positives FP (only automated CAC scores > 0). 
Specificity characterizes the algorithm’s ability to not falsely capture CAC regions: 𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 = 𝑇𝑁/(𝐹𝑃 + 𝑇𝑁)                                                                                     (2.42) 
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             (a)                           (b)                                (c)                             (d) 
 
         
                   (e)                                          (f)                                             (g) 
Figure 2.21: Example reference regions for quantitative segmentation evaluation. For each pair 
of images, the upper image is the intensity CT and the lower image shows the manual boundary. 
(a) AA; (b) aortic arch; (c) DA; (d) PT; (e) superior CVF; (f) middle CVF; (g) inferior CVF. 
          
             (a)                        (b)                        (c)                                 (d) 
Figure 2.22: Example reference regions for quantitative biomarker evaluation. (a) reference 
region for CAC; (b) reference regions for AC; (c) pulmonary artery reference diameter at 
bifurcation level; (d) AA diameter at bifurcation level. 
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            LM=0                            LM=1                           LM=2                         LM=3 
                
         LAD = 0                      LAD=1                     LAD=2                        LAD=3 
                
             LCX=0                          LCX=1                        LCX=2                           LCX=3 
             
               RCA=0                             RCA=1                          RCA=2                          RCA=3 
Figure 2.23: Example cases with different visual CAC scores for the four arteries. Red arrows 
indicate the CAC locations. 
2.3.2    Qualitative evaluation experiments 
 In the above sections, each segmentation algorithm has been quantitatively evaluated in a 
set of manually marked CT scans (evaluation set typically contains around 50 CT scans). This is 
also the standard quantitative evaluation procedure used in the literature for segmentation 
problems. However, to evaluate the general robustness of the algorithm, especially its ability to 
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be applied in a fully-automated setting without human intervention, a much larger dataset with 
thousands of scans is needed. Manually annotating reference regions on such large datasets is 
typically unrealistic. Therefore, the traditional quantitative evaluation method is not applicable. 
 In this study, a novel alternative method is used for evaluating the segmentation 
qualitatively through customized visualization and visual inspection (Reeves et al. 2017) [51]. 
The visual inspection mainly relies on the coronal and sagittal visualization of the segmented 
aorta, heart and PT (see Figure 2.24). They are evaluated together as the cardiac region 
segmentation. Evaluation in 2D axial image slices is also possible (see Figure 2.25) but is rarely 
used unless there is confusion that cannot be distinguished in the 3D visualization. Each cardiac 
segmentation is graded into one of the following three categories: 
Good: no visible error; 
Acceptable: errors exist but the segmentation is still usable for biomarker measurement; 
Unacceptable: major errors or algorithm failure, making the segmentation unusable. 
                     
                                                   
                (a)                                          (b)                                          (c) 
Figure 2.24: Customized visualization of cardiac segmentation in coronal view (upper row) and 
sagittal view (lower row). The visual segmentation grade is (a) Good; (b) Acceptable; (c) 
Unacceptable. Aorta (red), heart (green), PT (blue) together with lungs (pink) and bones (light 
grey) are shown.  
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Figure 2.25: Axial visualization of cardiac segmentation in two slices. The segmented aorta 
(red), heart (green), PT (blue) together with the colored lungs, fat, ribs, vertebrae are overlaid on 
the intensity CT images. 
 The datasets for large-scale qualitative evaluation based on visual inspection are: the 
VIA-ELCAP public dataset [70], the LIDC public dataset [71], a World Trade Center workers 
dataset WTC (research dataset), a LCS dataset FY from the Flight Attendants Medical Research 
Institute [73], a nuclear energy workers dataset QV (research dataset), and a high risk LCS 
dataset UN (research dataset). Number of different cases and imaging parameter settings of these 
datasets are summarized in Table 2.7. Note that sometimes one case contains multiple scans 
taken at different time points or taken at the same time but reconstructed with different 
algorithms. Therefore, the number of cases does not always equal the number of scans. All scans 
are non-contrast whole-chest CT with the majority being low-dose. Scans with major implant 
artifacts or very poor quality have been excluded. 
Table 2.7. Summary of datasets for large-scale qualitative evaluation of cardiac segmentation. 
Dataset Number of 
Cases (Include) 
Number of 
Scans (Include) 
Number of Scans 
(Exclude) 
Slice Thickness 
(mm) 
VIA-ELCAP 46 46 4 (8%) =1.25 
LIDC 318 318 10 (3%) <=1.25 
WTC 1454 3766 28 (0.7%) <=1.5 (3762 scans) 
2 (4 scans) 
FY 932 2137 0 (0%) <=1.25 
QV 1887 4672 6 (0.1%) =2 
UN 2985 9810 10 (0.1%) <=1.5 (9804 scans) 
=2 (6 scans) 
  46 
 
2.4    Evaluation results 
 Both quantitative and qualitative evaluation results are given in this section. For each 
evaluation result, relevant visualizations are also given such as the comparison between 
automated and manual regions. Section 2.4.1 gives the quantitative evaluation results on 
segmentation and biomarker measurements and section 2.4.2 gives the large-scale qualitative 
evaluation results on segmentation. 
2.4.1    Quantitative evaluation results 
 Aorta segmentation results and example images are given in Table 2.8 and Figure 2.26. 
The average DSC for PT segmentation is 0.88 (range=[0.74, 0.95]). The average DSC for CVF 
segmentation is 0.93 (range=[0.81, 0.99]). PT and CVF example segmentation outcomes are 
shown in Figures 2.27-2.28. 
Table 2.8. Quantitative evaluation results for aorta segmentation. Metrics include average DSC 
for the entire aorta and for AA, DA and arch (Arch); bias term Bpn; mean boundary distance µd in 
millimeters for AA, DA and Arch. For each term, the mean, standard deviation (s), maximum 
(max) and minimum (min) are given. 
 DSC 
(aorta) 
DSC 
(AA) 
DSC 
(DA) 
DSC 
(Arch) 
Bpn µd 
(aorta) 
µd 
(AA) 
µd 
(DA) 
µd 
(Arch) 
Mean 0.933 0.936 0.939 0.915 0.018 1.39 1.63 1.20 1.42 
s 0.014 0.019 0.020 0.022 0.054 0.19 0.33 0.29 0.22 
Max 0.963 0.972 0.973 0.955 0.123 1.79 2.68 1.96 1.95 
Min 0.907 0.889 0.881 0.863 -0.086 0.83 0.69 0.57 0.98 
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                (a)                              (b)                           (c)                           (d) 
Figure 2.26: Example aorta segmentation compared to the references in 4 cases. Upper row 
shows intensity CT image and lower row shows the comparison. In each color image, red is the 
overlapping region between automated and reference image, green only exists in the automated 
image and blue only exists in the reference image. The DSC and µd for each case are: (a) 0.962 
and 1.23mm; (b) 0.957 and 1.08mm; (c) 0.888 and 1.89mm; (d) 0.923 and 1.44mm. 
          
                 
                          
          (a)                     (b)                     (c)                       (d) 
Figure 2.27: Example PT segmentation compared to the references in 4 cases. Top row shows 
intensity CT image, middle row shows the comparison, and bottom row shows sagittal 
visualization of PT (blue), aorta (red) and heart (green). In each color image in the middle row, 
red is the overlapping region between automated and reference image, green only exists in the 
automated image and blue only exists in the reference image. The DSC for each case is: (a) 0.94; 
(b) 0.93; (c) 0.88; (d) 0.78. 
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                                      (a) 
           
                                          (b) 
           
                                       (c) 
Figure 2.28: Example CVF segmentation compared to the references in 3 cases. Each row 
corresponds to a case, where the 3 images are the 3 slices with manual boundaries from superior 
to inferior. For all images, red represents fat pixels in both the automated and reference regions, 
green represents those only in the automated region and blue only in the reference region. 
 The quantitative evaluation results for CAC biomarkers are shown in Tables 2.9-2.13. 
The CAC evaluation results compared to manual boundaries are summarized in Tables 2.9-2.10. 
The automated calcification score distributions of the CAC datasets used for visual scoring is 
listed in Table 2.11. The CAC evaluation results compared to visual scores are summarized in 
Tables 2.12-2.13. After evaluation using the whole dataset, the dataset is further partitioned into 
three subsets with different noise levels to evaluate the impact of image noise on the algorithm 
performance. Noise level is represented by the standard deviation of pixels in the automatically 
segmented heart region. Figure 2.29 shows the heart region noise distribution for the whole 
dataset. The three subsets are: low noise group (noise below 80HU) with 398 cases; medium 
noise group (noise between 80 and 110HU) with 499 cases; high noise group (noise above 
110HU) with 462 cases. The partition thresholds have been chosen so that each noise group 
would contain similar number of cases. Results on the three noise groups are shown in Tables 
  49 
2.14-2.15 and Figure 2.30. Sensitivity differences between the three noise groups are evaluated 
using Pearson Chi-squared test for its significance. The following sensitivities are significantly 
different from each other, i.e. p-value<0.05: all CACs low v.s. high (p=0.008); all CACs medium 
v.s. high (p=0.009); LM+LAD CAC low v.s. high (p<0.001); LM+LAD CAC medium v.s. high 
(p<0.001). Example labeled CACs are shown in Figure 2.31. 
Table 2.9. Pearson R between automated (Auto) and reference scores (Manual) for AS, VS, and 
MS. 
Pearson R AS VS MS 
Manual v.s. Auto 0.90 0.89 0.92 
 
Table 2.10. Confusion matrix (CM) between automated (Auto) and reference (Ref) risk 
categories. Low risk=1; moderate risk=2; moderately high risk=3; high risk=4. 
CM Auto=1 Auto=2 Auto=3 Auto=4 
Ref=1 18 1 1 0 
Ref=2 1 5 1 0 
Ref=3 0 1 5 3 
Ref=4 0 0 0 5 
 
Table 2.11. Statistics of AS scores for the whole dataset (all CACs and by artery). 
AS Number  
of Cases 
All CACs LM+LAD CAC LCX CAC RCA CAC 
Mean 1,359 391.9 213.5 78.76 99.7 
Median 1,359 71.0 35.0 0 0 
Range 1,359 [0, 6328.0] [0, 3657.0] [0, 4105.0] [0, 4836.0] 
Standard deviation 1,359 762.5 428.1 321.8 321.9 
 
Table 2.12. Spearman R between visual and automated scores (all CACs and by artery). 
Spearman R Number of Cases All CACs LM+LAD CAC LCX CAC RCA CAC 
Visual v.s. AS 1,359 0.87 0.82 0.66 0.72 
Visual v.s. VS 1,359 0.88 0.82 0.66 0.73 
Visual v.s. MS 1,359 0.87 0.82 0.66 0.72 
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Table 2.13. Labeling sensitivity and specificity (all CACs and by artery). 
Metric Number  
of Cases 
All CACs LM+LAD CAC LCX CAC RCA CAC 
Sensitivity 1,359 0.87 0.82 0.65 0.74 
Specificity 1,359 0.84 0.89 0.92 0.88 
 
 
Figure 2.29: Histogram of heart region noise on the whole dataset (1,359 scans). 
 
Table 2.14. Spearman R between visual and automated scores for the three noise groups (all 
CACs and by artery). 1 = low noise group (398 cases); 2 = medium noise group (499 cases); 3 = 
high noise group (462 cases). 
Spearman R All CACs LM+LAD CAC LCX CAC RCA CAC 
 1 2 3 1 2 3 1 2 3 1 2 3 
Visual v.s. AS 0.87 0.90 0.85 0.83 0.85 0.80 0.68 0.65 0.67 0.74 0.74 0.69 
Visual v.s. VS 0.88 0.90 0.86 0.83 0.85 0.80 0.68 0.65 0.68 0.75 0.74 0.69 
Visual v.s. MS 0.87 0.89 0.85 0.83 0.85 0.80 0.68 0.65 0.67 0.74 0.73 0.69 
 
Table 2.15. Labeling sensitivity and specificity for the three noise groups (all CACs and by 
artery). 1 = low noise group (398 cases); 2 = medium noise group (499 cases); 3 = high noise 
group (462 cases). 
Metric All CACs LM+LAD CAC LCX CAC RCA CAC 
 1 2 3 1 2 3 1 2 3 1 2 3 
Sensitivity 0.90 0.89 0.82 0.87 0.85 0.74 0.66 0.66 0.63 0.74 0.78 0.70 
Specificity 0.84 0.86 0.83 0.84 0.91 0.91 0.94 0.90 0.92 0.90 0.87 0.88 
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Figure 2.30: Bar plots showing the differences in correlation and sensitivity between the three 
noise groups. 
                
          (a)                             (b)                                  (c)                                  (d) 
Figure 2.31: Examples of correctly labeled CACs in a case. (a) and (b) show a coronal and a 
sagittal view with heart and aorta in light green; (c) and (d) show axial slices with labeled CACs. 
For colored CACs, LM+LAD CAC is in red, LCX CAC is in magenta, and RCA CAC is in blue.  
 For AC evaluation, the Pearson R is 0.99 for all three scores (AS, VS, MS) between 
automated and manual methods. The automated AS has a mean of 2937.0 (median=830.7, 
range=[0, 23160]). Figure 2.32 shows example cases with different levels of aortic calcification. 
 For PT and AA diameter evaluation, the Pearson R is 0.80 between reference pulmonary 
artery diameter and automated PT diameter, 0.93 between reference and automated AA diameter, 
and 0.81 between reference and automated diameter ratio. The Bland-Altman LOA results are 
listed in Table 2.16. 
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         (a)                    (b)                      (c)                          (d) 
Figure 2.32: Four example cases of AC (red) with aorta (light green) in sagittal view. The AS for 
the four cases are: (a) 420; (b) 1356; (c) 3038; (d) 18295. 
Table 2.16. Bland-Altman LOA results of diameter comparison. PA=main pulmonary artery and 
Mean diff=Automated-Reference. 
Automated Reference Mean diff LOA Range (Reference) 
PT diameter PA diameter 0.60 [-4.23, 5.43] [19.16mm, 35.01mm] 
AA diameter AA diameter -0.53 [-3.93, 2.85] [22.90mm, 44.35mm] 
PT/AA ratio PA/AA ratio 0.03 [-0.12, 0.18] [0.53, 1.10] 
 
2.4.2    Qualitative evaluation results 
 The visual inspection results of cardiac segmentation for the large-scale qualitative 
evaluation are summarized in Table 2.17. 
Table 2.17. Qualitative visual evaluation results for cardiac segmentation. For each grade 
category, both number of scans and percentage among all scans in this dataset are given. 
Dataset Number  
of Scans 
Good Acceptable Unacceptable 
VIA-ELCAP 46 (100%) 44 (96%) 2 (4%) 0 (0%) 
LIDC 318 (100%) 293 (92%) 19 (6%) 6 (2%) 
WTC 3766 (100%) 3247 (86%) 320 (8%) 199 (5%) 
FY 2137 (100%) 1784 (83%) 200 (9%) 153 (7%) 
QV 4672 (100%) 3854 (82%) 311 (7%) 507 (11%) 
UN 9810 (100%) 8451 (86%) 520 (5%) 839 (9%) 
All 20749 (100%) 17673 (85%) 1372 (7%) 1704 (8%) 
 
2.5    Discussion 
 The aorta segmentation algorithm has good agreement with manually marked aorta 
boundaries (average DSC = 0.93, average boundary distance 1.39mm). Based on Bpn, the 
algorithm is biased towards over-segmentation. This is mainly because aorta is surrounded by 
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tissues with very similar intensity values in instances where there is only a small number of fat 
pixels adjacent to the aorta. Therefore, a small percentage of the image rays have not terminated 
correctly at the aorta surface. In very few cases (less than 0.5%), aorta segmentation fails in the 
centerline tracking stage due to 1) extremely high level of image noise (over 250HU inside soft 
tissue), or 2) abnormal anatomical structures (for example descending aorta on the right instead 
of the left side of the body). 
Segmentation of the PT proves to be more challenging than that of the aorta (average 
DSC = 0.88) because it is a much smaller region and is not as well-defined as the aorta. In 
addition, the segmentation of PT relies on the segmentation of aorta, therefore making it possible 
for aorta segmentation errors to propagate to PT. Similarly to aorta segmentation, the major 
cause of incorrect PT boundary is adjacent soft tissues within similar intensity values. 
The heart region segmentation is not validated against manual markings because the 
segmentation target is the general heart region rather than the actual heart boundary, which is not 
visible in LDCT. Therefore as long as the segmented heart region covers all coronary arteries for 
the purpose of CAC evaluation, it is considered acceptable. 
 Detection of CAC is challenging in LDCT for a number of reasons including high noise 
level and heart motion artifacts. Techniques to reduce the impact of noise such as image filtering 
can also lead to the exclusion of small calcification regions. However, when comparing 
automated CAC with manual CAC, the automated CAC still has good agreement with reference 
CAC from low-dose scans (AS correlation 0.90, 33 cases correct risk categories and 7 cases one 
category off). 
 Automated CAC scores (all and by artery) are also compared to visual categorical scores 
from a much larger dataset with 1,359 LDCT scans. The Spearman R is 0.87 for all CACs. The 
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agreement for individual artery varies: it is the highest for LM+LAD calcification (Spearman R 
= 0.82) and the lowest for LCX calcification (Spearman R = 0.66). This is mostly because LCX 
contains the least amount of calcification and is more easily impacted by image filtering. The 
calcification in this artery also often locates at the branching point of the LM artery, making it 
difficult to separate the two regions. In addition, errors occur in a small number of cases where 
using geometric locations alone cannot distinguish CAC from other calcification in the proximity 
(see Figure 2.33 for correctly and incorrectly labeled LCX CAC). 
                
               (a)                                      (b)                                           (c) 
Figure 2.33: Examples of CAC segmentation and labeling errors. (a) correctly labeled LCX CAC 
in magenta; (b) other calcification (in magenta) mistaken as LCX CAC; (c) LCX CAC (inside 
the blue circle) not separated from other LM+LAD CAC (in red). 
Image noise level has an impact on both the calcification detection accuracy and 
sensitivity. Compared to images with lower noise, the high noise group (noise level above 
110HU) has lower correlation and detection sensitivity overall. However, the difference is not 
obvious between low and medium noise groups and their difference is not statistically 
significant. 
 Both the AC and CVF segmentation have good agreement with manual markings. The 
Pearson R between automated and manual AC AS is 0.99. AC can be segmented using a 
relatively simple model because it is likely to be the only high-intensity structure on the surface 
of aorta. The DSC for CVF segmentation is 0.93. CVF under-segmentation occurs occasionally 
when the CVF anterior boundary has a complex shape and cannot be modeled accurately using a 
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rectangle. 
It should also be noted that currently the calcification segmentation algorithms do not 
address the cardiac region metal implant issue or perform any implant detection. None of the 
scans in the evaluation datasets contains any major cardiac implants. 
For the evaluation of PT and AA diameters, the automated and reference AA diameters 
have good agreement with good correlation (Pearson R = 0.93) and small LOA ([-3.93mm, 
2.85mm]). The PT diameters and the diameter ratio have lower agreement (Pearson R = 0.80 and 
0.81). This is mainly because the two PT measurements are taken at different locations and the 
PT diameter appears to be slightly larger than the main pulmonary artery diameter at the 
bifurcation level used clinically. It should also be noticed that there is likely to be a true 
difference in diameter measured from an axial image slice versus diameter measured from the 
3D segmentation. 
Through large-scale visual evaluation of cardiac segmentation, it is shown that the 
algorithms are robust when applied to a large dataset of heterogeneous CT scans. Among the 
20,749 CT scans, 19,045 scans (92%) have good or acceptable result and for the 8% 
unacceptable scans, only about 3% is caused by incorrect cardiac segmentation itself. The 
remaining 5% out of the 8% belong to segmentation failures caused by incorrect segmentation of 
other organs that cardiac segmentation depends on, such as airway and ribs segmentation. 
2.6    Conclusion 
In conclusion, fully-automated algorithms have been developed for the segmentation of 
cardiac organs and the measurement of cardiac disease related image biomarkers in the context 
of low-dose chest CT scans. The cardiac organ segmentation includes the thoracic aorta, the 
pulmonary artery trunk, and the general heart region. The cardiac biomarker segmentation and 
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measurement includes the segmentation and measurement of CAC, AC and CVF. The aorta and 
PT diameters are also measured. The segmentation algorithms have shown both precision and 
robustness in the quantitative and qualitative evaluations. For quantitative evaluation, the 
average DSC is 0.93 for aorta, 0.88 for PT, and 0.93 for CVF. For qualitative evaluation on a 
large dataset of 20,749 chest CT scans, 17,673 scans (85%) have good cardiac segmentation 
results, 1,372 scans (7%) have acceptable cardiac segmentation results, and 1,704 scans (8%) 
have unacceptable results, the majority of which caused by unacceptable segmentation of other 
regions that cardiac segmentation depends on. The automatically measured biomarkers have 
shown good agreement with biomarkers extracted from manual annotations or visual ratings. The 
Pearson R between automated and manual AS is 0.90 for CAC and 0.99 for AC. The Spearman 
R between automated AS and visual scores is 0.87 for all CAC, and 0.82, 0.66, 0.72 for the 
individual artery groups. The Pearson R between automated and manual PT diameters and AA 
diameters is 0.80 and 0.93. The fully-automated cardiac region CAD algorithms provide the 
opportunity to evaluate cardiac disease risk level for a LCS population.
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CHAPTER 3 
 
LUNG DISEASE BIOMARKER MEASUREMENT 
The primary purpose of LCS is the early-detection of pulmonary nodule, an indicator of 
lung cancer. LCS CT scans can also be used for the characterization of other lung region diseases 
such as the ILD and the thickening of pleural surface. 
In contrast to CT scans obtained in a clinical setting for the evaluation of advanced lung 
diseases, participants of LCS are asymptomatic. Therefore it is very unlikely for advanced stage 
lung diseases to manifest in such scans. For this reason, the lung disease related algorithms in 
this dissertation are all designed for early-stage lung diseases. Three different disease 
measurements are presented: 
1) Section 3.1 describes the characterization of small pulmonary nodule malignancy status and 
the impact of nodule size on the characterization outcome using LCS LDCT data; 
2) Section 3.2 presents the identification of early-stage ILD by applying an automated algorithm 
to differentiate early-stage Usual Interstitial Pneumonia (UIP) from normal cases in LDCT; 
3) Section 3.3 presents two algorithms to detect early-stage pleural surface thickening from 
LDCT. The first method measures the distance between pleural surface and ribs and the second 
method is based on the pleural surface shape.  
3.1    Pulmonary nodule characterization 
The major contribution of the nodule characterization algorithm presented in this 
dissertation is the construction of various training and evaluation datasets to assess the impact of 
nodule size on characterization outcome and to find the optimal training strategies (Reeves et al. 
2016) [74]. The subsections are organized as follows: 
1) section 3.1.1 presents the nodule dataset used in this study including the number of nodules 
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and their size distribution; 
2) section 3.1.2 describes the image features computed from each nodule, which are used for 
machine learning classification; 
3) section 3.1.3 describes the design of experiments and section 3.1.4 gives their corresponding 
results; 
4) section 3.1.5 presents discussion and section 3.1.6 presents conclusion. 
3.1.1    Construction of datasets 
 The whole dataset consists of nodule images from the two largest LCS studies, the 
International Early Lung Cancer Action Program (I-ELCAP) [6] and the National Lung Cancer 
Screening Trial (NLST) [75]. Malignant nodules are determined through pathological diagnosis 
and benign nodules are determined through pathological diagnosis or 2 years of no clinical 
change. Non-solid nodules are excluded from the dataset due to their very different visual 
presentation and slow growth rate. Only solid nodules or the solid component of part-solid 
nodules are included in the dataset. The whole dataset consists of a total of 736 nodules (412 
malignant and 324 benign), among which 259 are from I-ELCAP and 477 are from NLST. 
Details of the whole dataset are listed in Table 3.1. All CT scans have a slice thickness of 3.2mm 
or less, with the majority of the scans less than or equal to 2.5mm (698/736=95%). 
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Table 3.1. Nodule numbers and equivalent diameters (in mm) statistics for the whole dataset and 
for I-ELCAP, NLST separately.  
Dataset Status Number Diameter Range (Median) 
All Malignant 412 [3.00, 29.14] (9.21) 
Benign 324 [3.11, 27.11] (5.84) 
Both 736 [3.00, 29.14] (7.33) 
I-ELCAP Malignant 167 [3.72, 29.14] (12.17) 
Benign 92 [3.25, 27.11] (9.47) 
Both 259 [3.25, 29.14] (11.28) 
NLST Malignant 245 [3.00, 27.60] (7.60) 
Benign 232 [3.11, 21.43] (5.15) 
Both 477 [3.00, 27.60] (6.15) 
 
To assess the impact of nodule size distribution on characterization results, a size-
balanced subset is constructed from the full dataset. This subset (GA) contains 163 malignant 
and 163 benign nodules. The two types of nodules are selected so that they have as similar size 
distribution (equivalent diameter) as possible. Details of GA are listed in Table 3.2. GA is further 
divided into 3 subsets of size-balanced malignant and benign nodules: G6 (diameter from 5 to 7 
mm), G8 (diameter from 7 to 9 mm), and G12 (diameter from 9 to 14 mm). Details of these 3 
subsets are also listed in Table 3.2. Figure 3.1 shows the size distribution for the whole dataset 
and GA. 
 Table 3.2. Nodule numbers and equivalent diameters (in mm) statistics for the GA set and for 
each binned subset of GA. 
Dataset Status Number Diameter Range (Median) 
GA Malignant 163 [5.01, 14.00] (7.21) 
Benign 163 [5.02, 13.91] (7.27) 
Both 326 [5.01, 14.00] (7.22) 
G6 Malignant 73 [5.01, 6.98] (6.04) 
Benign 73 [5.02, 6.97] (6.06) 
G8 Malignant 46 [7.04, 8.96] (7.65) 
Benign 46 [7.03, 8.84] (7.71) 
G12 Malignant 44 [9.05, 14.00] (11.72) 
Benign 44 [9.02, 13.91] (11.41) 
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                                     (a)                                                                        (b) 
Figure 3.1: Malignant and benign nodule size distribution. (a) whole dataset; (b) size-balanced 
subset GA divided into three subsets: G6, G8, G12. 
3.1.2    Computation of image features 
Each nodule in the dataset has its intensity CT image as well as a binary segmented 
nodule mask region using our previously published method (Reeves et al. 2006) [76]. Both the 
intensity and the mask images have been resampled to 0.25mm3 isotropic resolution. Image 
features designed in our previous study (Jirapatnakul et al. 2007) [77] are computed based on the 
resampled intensity image and the nodule mask. There is a total of 46 image features, which can 
be grouped into 4 categories: morphological, density, surface curvature and margin gradient. A 
brief description is given for each category. 
Morphological: they describe the 3D segmented nodule region shape and are derived from image 
moments (Prokop et al. 1992) [78]. The specific morphological features are: volume, surface 
area, volume to surface area ratio, compactness, sphericity, attachment ratio, length/width/height 
of the ellipsoid of inertia, ratios of the length/width/height to one another, the roll/pitch/yaw of 
the ellipsoid of inertia and the scale-normalized second-order morphological moment. 
Density: they are derived from the gray-level intensity value of the image. The specific density 
features are: density mass, mean density, the standard deviation, skewness and kurtosis of the 
density histogram, length/width/height of the density-based ellipsoid of inertia, ratios of the 
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length/width/height of the density-based ellipsoid of inertia to one another and the scale-
normalized second-order densitometric moment. 
Surface curvature: they are computed from a smoothed polygonal tessellation of the segmented 
nodule region as described in (Jirapatnakul 2011) [79]. The following statistics of the curvature 
distribution are used as surface curvature features: mean, minimum, maximum, range, standard 
deviation, skewness and kurtosis. 
Margin gradient: they measure the density changes occurring at the nodule margin, i.e. the 
segmented nodule boundary and the surrounding lung parenchyma. A surface tessellation of the 
nodule is computed and the surface normals are recorded. Image gradient samples are taken 
along each surface normal and the highest sample is recorded. The following statistics of the 
highest gradient samples are used as margin gradient features: mean, minimum, maximum, 
range, standard deviation, skewness and kurtosis. 
3.1.3    Experiments and evaluation 
For classification, five standard machine learning classifiers are used: the distance-
weighted k-nearest-neighbors classifier (dwNN) (Dudani 1976) [80], the Support Vector 
Machine (SVM) classifier (Joachims 1999) [81] with a polynomial kernel (SVM-P), the SVM 
with a Radial Basis Function kernel (SVM-R), the logistic regression classifier (LOG) and the 
size threshold classifier (Size-C). 
For dwNN, SVM-P, SVM-R and LOG classifiers, 5-fold cross validation is used for 
training and evaluation. In the training stage, 5-fold cross validation is used to divide the training 
set into training and validation sets for parameter optimization. The classifiers have probabilistic 
output and the final characterization outcome is represented by the average Receiver Operating 
Characteristic (ROC) curve (Fawcett 2006) [82] from the 5-fold as well as the area under this 
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ROC curve (AUC). For Size-C classifier, nodule size is the only feature and the ROC curve is 
computed by varying a size threshold through the size range in the dataset. At each step, a pair of 
sensitivity and (1-specificity) is obtained, based on which the ROC and AUC is computed. Two 
experiments are performed to validate the following hypotheses: 
1) Nodule size has a major impact on characterization performance; 
2) To characterize nodule status conditioned on a certain size range (i.e. evaluation on a size-
balanced dataset), the classifier should be trained on a size-balanced dataset. 
The two hypotheses are validated with the following two experiments listed in 
Experiment 3.1 and 3.2. 
 
Experiment 3.1: Evaluation of nodule size impact on characterization outcome 
1) Perform cross-validation on the whole dataset (unbalanced); 
2) Perform cross-validation using size-unbalanced training dataset and size-balanced 
evaluation dataset GA; 
3) Perform cross-validation using size-balanced dataset GA. 
 
 
 
Experiment 3.2: Optimal training strategy when evaluating on a size-balanced dataset  
1) Perform cross-validation using unbalanced training set and size-binned evaluation set (G6, 
G8, G12) (training and evaluation have the same size range); 
2) Perform cross-validation using G6, G8, and G12; 
3) Combining the best classifier trained on each individual bin and evaluated on GA through 
cross-validation; 
4) Repeat steps 1-3 while replacing G8 and G12 with a combined larger bin G8+G12. 
 
 
 The two experiments are illustrated in Figure 3.2. For each experiment, besides the AUC 
value, each classifier is also compared to the AUC from the Size-C and the difference is defined 
as an Incremental AUC (IAUC) as it indicates the performance increase conditioned on a certain 
size. Both AUC and IAUC will be reported in the results. The p-values between the ROC curves 
(Size-C v.s. Others) are also computed to indicate the statistical significance of the IAUC 
  63 
(DeLong et al. 1988) [83]. 
 
Figure 3.2: Organization of experiment 3.1 and 3.2. 
3.1.4    Results 
 Results from Experiment 3.1 and 3.2 are summarized in Tables 3.3-3.5. The 
representative ROC plots are shown in Figure 3.3. 
Table 3.3. Experiment 3.1 results. AUCs, IAUCs, and p-values under different training and 
evaluation conditions. 
Training Evaluation Result dwNN SVM-P SVM-R LOG Size-C 
All  
(unbalanced) 
All  
(unbalanced) 
AUC 0.750 0.772 0.772 0.761 0.725 
IAUC 0.025 0.047 0.047 0.036 - 
p-value =0.09 <0.001 <0.001 =0.15 - 
All 
(unbalanced) 
GA 
(balanced) 
AUC 0.584 0.639 0.642 0.564 0.510 
IAUC 0.074 0.129 0.132 0.054 - 
p-value =0.14 =0.01 =0.009 =0.11 - 
GA 
(balanced) 
GA 
(balanced) 
AUC 0.700 0.708 0.699 0.624 0.510 
IAUC 0.190 0.198 0.189 0.115 - 
p-value <0.001 <0.001 <0.001 =0.003 - 
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Table 3.4. Experiment 3.2 results. Best performance for the individual bins from GA under 
different training and evaluation conditions. All p-values are less than 0.001 and are not shown 
in the table. 
Training Evaluation Results Size-C AUC 
G6 size range 
(unbalanced binned) 
G6 
(balanced binned) 
AUC 0.646 0.546 
IAUC 0.100 
classifier dwNN 
G6 
(balanced binned) 
G6 
(balanced binned) 
AUC 0.691 0.546 
IAUC 0.145 
classifier LOG 
G8 size range 
(unbalanced binned) 
G8 
(balanced binned) 
AUC 0.699 0.500 
IAUC 0.199 
classifier SVM-P 
G8 
(balanced binned) 
G8 
(balanced binned) 
AUC 0.759 0.500 
IAUC 0.259 
classifier SVM-P 
G12 size range 
(unbalanced binned) 
G12 
(balanced binned) 
AUC 0.745 0.507 
IAUC 0.238 
classifier SVM-R 
G12 
(balanced binned) 
G12 
(balanced binned) 
AUC 0.759 0.507 
IAUC 0.252 
classifier SVM-P 
G8+G12 size range 
(unbalanced binned) 
G8+G12 
(balanced binned) 
AUC 0.740 0.503 
IAUC 0.243 
classifier SVM-R 
G8+G12 
(balanced binned) 
G8+G12 
(balanced binned) 
AUC 0.780 0.503 
IAUC 0.277 
classifier SVM-P 
 
Table 3.5. Experiment 3.2 results. AUCs, IAUCs, and p-values after combining the best results 
from each individual bin. Two combination methods are used. 
Training Evaluation Combining Method Result  Size-C AUC 
GA size range 
(unbalanced) 
GA 
(balanced) 
G6, G8, G12 
(balanced 3 bins) 
AUC 0.666 0.510 
IAUC 0.156 
p-value =0.002 
GA 
(balanced) 
GA 
(balanced) 
G6, G8, G12 
(balanced 3 bins) 
AUC 0.726 0.510 
IAUC 0.216 
p-value <0.001 
GA size range 
(unbalanced) 
GA 
(balanced) 
G6, G8+G12 
(balanced 2 bins) 
AUC 0.684 0.510 
IAUC 0.174 
p-value <0.001 
GA 
(balanced) 
GA 
(balanced) 
G6, G8+G12 
(balanced 2 bins) 
AUC 0.742 0.510 
IAUC 0.232 
p-value <0.001 
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                                    (a)                                                                         (b) 
 
                                    (c)                                                                         (d) 
Figure 3.3: Result ROC curves. (a)-(c) are average ROC curves from experiment 3.1. (a) training 
and evaluation on all unbalanced data; (b) training on unbalanced and evaluation on balanced 
GA; (c) training and evaluation on balanced GA; (d) compares the best performance ROC curves 
from experiment 3.1 and 3.2 under different training and evaluation conditions. 
3.1.5    Discussion 
 The two hypotheses have been validated through the experiments. First, nodule size plays 
an important role and without balancing for size between malignant and benign nodules, the 
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characterization outcome mostly reflects the natural size distribution. This can be seen in 
experiment 3.1 training and testing on all unbalanced data: the best classifier SVM-P and SVM-
R (AUC=0.772) is just slightly better than using size alone (IAUC=0.047). Furthermore, this 
trained classifier has much lower AUC when evaluated on a size-balanced testing set (best 
AUC=0.642). However, the performance increases when the classifier is re-trained on a size-
balanced set (best AUC=0.708), showing that balanced training is superior to unbalanced 
training when evaluated on a balanced testing set. 
 This is further proved in experiment 3.2. For evaluation on each individual bin, balanced 
training always outperforms unbalanced training even though both training methods use data 
from the same size range. The best overall performance when evaluated on GA is obtained by 
combining the best performance in individual bins (best AUC=0.742 after combining G6 with 
G8+G12). 
 It should also be noted that evaluation on a size-balanced set shows the performance of 
the features and classifiers conditioned on a fixed size range, as Size-C AUC for balanced 
evaluation set is close to random guessing (Size-C AUC close to 0.500). It is also observed that 
the larger size bins have better performance (G8 and G12 best AUC=0.759 while G6 best 
AUC=0.691). This could be caused by the fact that G6 nodules are much smaller in volume than 
G8 and G12 and have much higher percentage partial voxels, therefore making the image 
features less reliable. 
There are some limitations to this study. First, there is no compensation for image noise, 
different imaging and scanner parameters; second, although a dataset with 736 nodules is 
considered fairly large for medical image related research, it is still far too small for many 
standard machine learning approaches. 
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3.1.6    Conclusion 
In conclusion, the size difference between malignant and benign nodules has a large 
impact on nodule status characterization and without taking this into consideration, 
characterization outcome may be overly optimistic. This can be avoided by evaluating on a size-
balanced testing set. 
Nodule characterization system should reflect the difference between malignant and 
benign nodules conditioned on a certain size range rather than the natural size difference between 
the two types. Performance of such system can be greatly improved by training on size-balanced 
nodules. Performance can be further improved by combining the best classifiers trained on size-
balanced nodules within a small size range. 
3.2    ILD identification 
 ILD is a group of lung parenchymal diseases. Common ILD types include usual 
interstitial pneumonia (UIP), nonspecific interstitial pneumonia (NSIP), hypersensitivity 
pneumonitis, and sarcoidosis. Some ILD types have known causes while many others are 
idiopathic. For example, hypersensitivity pneumonitis is often caused by exposure to allergens. 
Different ILD subtypes usually have different spatial distribution in terms of diseased lung 
parenchymal tissues (see Figure 3.4). Salvatore et al. (2016) [84] have shown that a common UIP 
pattern is subpleural, basilar-predominant lung fibrosis with traction bronchiectasis, ground-glass 
opacities, and reticulations without honeycombing and a possible NSIP pattern is central fibrosis. 
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                     (a)                                                (b) 
Figure 3.4: Example image slices from (a) an UIP and (b) an NSIP case showing different spatial 
distribution of diseased lung tissues (red arrows).  
 In this dissertation, a fully-automated algorithm (Xie et al. 2017) [85] has been developed 
to differentiate early-stage UIP from normal cases from LDCT scans. The algorithm captures the 
spatial distribution of lung fibrosis in the UIP cases by partitioning the lung into equal-volume 
subsections and the abnormality is characterized by a fractional high-density feature. In the 
subsections below, section 3.2.1 describes the lung partitioning algorithm and section 3.2.2 gives 
the fractional high-density feature. Section 3.2.3 presents the experiments and section 3.2.4 lists 
the corresponding results. Discussion and conclusion are given in section 3.2.5 and 3.2.6. 
3.2.1    Equal-volume lung partitioning 
The equal-volume lung partitioning method partitions the lung region into subsections 
with the same volume from three different directions: superior to inferior, anterior to posterior, 
and left to right. Then the partitions from the three directions are combined together to form the 
final partitions for each lung. This method is applied to the left and right lungs separately. The 
two lungs are segmented and separated using a previously developed algorithm (Kostis et al. 
2003) [46]. The partitioning algorithm is described in Algorithm 3.1. 
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Algorithm 3.1 Lung partitioning algorithm 
1) Perform equal-volume partitioning from superior to inferior direction using planes 
perpendicular to the image z-axis (e.g. intersection of coronal and sagittal planes) (see 
Figure 3.5 (a)); 
2) Perform equal-volume partitioning from anterior to posterior direction in each axial slice 
using planes perpendicular to the image y-axis (e.g. intersection of sagittal and axial 
planes). Partitions in each image slice are combined to form the anterior to posterior 
partitions for the entire lung (see Figure 3.5 (b)-(c)); 
3) Perform equal-volume partitioning from left to right in each axial slice by scanning lines of 
pixels parallel to the image x-axis (e.g. intersection of coronal and axial planes). Each line 
is partitioned into segments of the same length and partitions from all lines are combined 
together to form the left to right partitions for the entire lung (see Figure 3.5 (d)-(e)); 
4) Combine the partitions from step 1-3 resulting in the final subsection partitioning for the 
entire lung. If there is n partitions in each direction, the total number of subsections for 
each lung is n3 (Figure 3.6 shows examples for n=3 and n=4). 
 
 
       
                  (a)                                            (b)                                                    (c) 
      
                  (d)                                                 (e) 
Figure 3.5: Lung partitioning visualization (3 partitions in each direction). (a) superior to inferior 
partitions in a coronal view; (b) shows the anterior to posterior partitions in a 3D axial view; (c) 
shows the anterior to posterior partitions in an axial slice; (d) shows the left to right partitions in 
a coronal view; (e) shows the left to right partitions in an axial slice. 
  70 
           
                  (a)                                    (b)                                      (c) 
 
           
                 (d)                                    (e)                                       (f) 
Figure 3.6: Combined partitions with 27 and 64 subsections. (a)-(c) show 27 subsections in a 
coronal view, a sagittal view, and an axial slice; (d)-(f) show 64 subsections in a coronal view, a 
sagittal view, and an axial slice. 
 Image features can be computed from each subsection and then combined together. The 
equal-volume strategy ensures that each subsection contains the maximum number of pixels for 
feature computation. Another lung partitioning based ILD characterization method has been 
developed by Depeursinge et al. (2015) [86]. Compared to their method, this algorithm is more 
general and allows for different numbers of equal-volume partitions. 
3.2.2    Computation of fractional high-density features 
 For early-stage UIP cases, the abnormal lung tissues do not typically exhibit very 
distinguishable texture features. Therefore, a classic fractional high-density feature is used to 
capture the UIP fibrosis regions. The high-density range of [-600HU, -250HU] is defined by 
Lederer et al. (2009) [87]. This range characterizes subclinical parenchymal lung disease while 
excluding more dense areas such as complete atelectasis, medium to large blood vessels and 
pulmonary nodules. In each subsection i, the fractional high-density measurement hi is computed 
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as the fraction of pixels in that subsection within the range of [-600HU, -250HU]. Algorithm 3.2 
describes the combination of hi from all subsections for each case. 
 
Algorithm 3.2 ILD feature vector computation for the whole lungs 
1) Denote the number of subsections in each lung as n. Denote the left and right lung feature 
vectors as Hleft and Hright: 𝐻)"l( = {ℎ)"l(I, ℎ)"l(M, … , ℎ)"l(+}                                                                                     (3.1) 𝐻'R,²( = {ℎ'R,²(I, ℎ'R,²(M, … , ℎ'R,²(+}                                                                             (3.2) 
2) Combining Hleft and Hright through concatenation, resulting in a feature vector Hall of length 
2n: 𝐻|)) = {𝐻)"l(, 𝐻'R,²(}                                                                                                       (3.3) 
3) Combining Hleft and Hright through selecting the maximum value between the two lungs, 
resulting in a feature vector Hmax of length n: 𝐻|; = {max ℎ)"l(I, ℎ'R,²(I ,max ℎ)"l(M, ℎ'R,²(M , … ,max	(ℎ)"l(+, ℎ'R,²(+)}           (2.4) 
 
 
 Example hi measurements in a UIP lung and a normal lung are shown in Figure 3.7. It 
can be observed that the high-density pixel distribution is different for the UIP and the normal 
case. This is also demonstrated in Figure 3.8 when plotting the hi values in the 27 subsections for 
the UIP and the normal lung. 
           
           UIP                   UIP hi pixels                   Normal   Normal hi pixels 
Figure 3.7: High-density (hi) pixels in an UIP lung and a normal lung. Each color corresponds to 
a different subsection (27 subsections in total). 
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                         (a) UIP Hright                                      (b) Normal Hright             (c) Ordering 
Figure 3.8: The distribution of Hright for the same UIP and normal case shown in Figure 3.7 (27 
subsections in each lung). (a) UIP lung Hright distribution; (b) normal lung Hright distribution; (c) 
subsection number ordering in each layer (superior, middle and inferior). 
3.2.3    Experiments and evaluation 
 The evaluation dataset consists of 56 normal cases and 51 UIP cases from different 
subjects. All CT scans are low-dose non-contrast and thin-slice (0.5-1.25mm slice thickness). All 
scans have been visually inspected by a radiologist to establish their status as normal or UIP. 
Normal cases do not exhibit ILD related patterns. However, they may contain other types of 
abnormalities such as nodules or lung atelectasis (see Figure 3.9). 
 
                 (a)                                   (b)                                    (c) 
Figure 3.9: Example UIP and normal cases in the evaluation dataset. (a) UIP case (red arrows 
indicate abnormal regions); (b) normal case with a ground glass opacity indicated by the green 
arrow; (c) normal case with lung atelectasis. 
 The automated lung partitioning and fractional high-density feature extraction method is 
applied to each case to compute the Hall and Hmax features. Hall and Hmax are evaluated separately. 
Lung partitioning number n is also varied: n = 1, 8, 27, and 64. An SVM classifier with a radial 
basis function (RBF) kernel is used to classify the cases into normal or UIP using these features 
and ten-fold cross-validation is used. The average AUC is used as the evaluation metric. The 
statistical significance of the difference between the two ROC curves is evaluated using the 
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DeLong test [83]. 
3.2.4    Results 
 The Hleft and Hright distributions for the UIP cohort and the normal cohort without 
partitioning (partition number n = 1) are shown in the histograms in Figure 3.10. After 
partitioning each lung into 27 subsections, the hlefti and hrighti averaged over the entire cohort are 
shown in Figure 3.11. Tables 3.6-3.7 show the AUC values for each partition number n and for 
both Hall and Hmax. The p-values between no partition (n = 1) and with partitions (n > 1) are also 
computed and listed in Tables 3.6-3.7. For the same n number, ROC using Hall is compared to 
ROC using Hmax and there is no statistically significant difference between them (p-value > 
0.05). 
 
 
 
Figure 3.10: Histogram of Hleft and Hright without partitioning for the UIP and the normal cohort. 
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Figure 3.11: Averaged hlefti and hrighti for the UIP and the normal cohort (27 subsections in each 
lung). 
Table 3.6. Classification average AUC values using Hall with different numbers of partitions n in 
each lung. 
Partition number n 
(Feature length = 2n) 
AUC p-value 
(compared to n=1) 
n= 1 0.85 - 
n = 8 0.92 0.14 
n = 27 0.95 0.026 
n = 64 0.94 0.035 
 
Table 3.7. Classification average AUC values using Hmax with different numbers of partitions n 
in each lung. 
Partition number n 
(Feature length = n) 
AUC p-value 
(compared to n=1) 
n = 1 0.85 - 
n = 8 0.92 0.12 
n = 27 0.93 0.056 
n = 64 0.93 0.064 
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3.2.5    Discussion 
 The automated algorithm is able to robustly separate early-stage UIP from normal cases 
with a highest AUC of 0.95. The fractional high-density measurement is useful in capturing the 
abnormal tissues in UIP cases without capturing major vessels or nodules. Although the 
transition region between vessels and lung parenchyma is also included by the high-density 
range, this happens evenly for both UIP and normal cases and do not seem to have a major 
impact on the outcome (see Figure 3.12). 
    
       UIP case 1                  UIP case 2                   Normal case 1              Normal case 2 
Figure 3.12: Example UIP cases and normal cases with high-density pixels in magenta. 
 The spatial distribution of lung fibrosis is different for the UIP and the normal cohort as 
shown in Figure 3.11. While normal cases have very similar hi values across all subsections, the 
UIP cases have a much higher hi value in the inferior and posterior regions. This phenomenon 
can be captured through lung partitioning. When partition number increases from n = 1 to n = 27, 
the AUC increases from 0.85 to 0.95 with statistical significance (p-value = 0.026). However, 
when n is further increased to 64, the AUC values does not further increase. One potential reason 
is that when n further increases, the number of pixels in each subsection decreases, making the 
measurement less robust. 
 There is not a statistically significant difference between using Hall and using Hmax 
although Hall leads to higher AUC values. In fact, based on the hi distribution shown in Figure 
3.11, the UIP patterns appear to be somewhat bilateral. 
 In a small number of regions, the hi measurement has incorrectly captured certain regions 
in normal cases such as the lung atelectasis regions (see Figure 3.13 (a)) and the dense region 
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caused by heart motion (see Figure 3.13 (b)). 
           
                            (a)                                                                 (b) 
Figure 3.13: Example normal cases with high hi values (high-density pixels in magenta). (a) lung 
atelectasis (red arrow); (b) ung atelectasis (red arrow) and heart motion (green arrow). 
 This algorithm has the potential to be extended to distinguish between different ILD 
subtypes such as UIP versus NSIP in the future when more data become available. Using the 
established lung partitioning model, additional image features can be easily incorporated. 
3.2.6    Conclusion 
 In conclusion, a fully-automated algorithm has been developed to distinguish early-stage 
UIP cases from normal cases in LDCT. The algorithm partitions the lung region into equal-
volume subsections and computes a fractional high-density feature for each subsection. It is able 
to distinguish early-stage UIP from normal cases with a highest AUC of 0.95 (with 27 
subsections). Using lung partitioning over not partitioning shows a statistically significant 
improvement in AUC value. This algorithm may be used to aid the diagnosis of early-stage UIP 
in the context of LDCT. 
3.3    Pleural thickness measurement 
Pleural thickening refers to the thickening of visceral pleura and can be induced by 
exposure to asbestos (Gevenois et al. 1998) [37]. It is often found in patients with malignant 
pleural mesothelioma, a usually fatal disease. However, the target in this study is to detect the 
early-stage subtle pleural thickening regions rather than the much more severe pleural thickening 
manifesting in malignant mesothelioma cases. 
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In this study, two different methods are designed to capture potential pleural thickening 
in a cohort exposed to the Libby vermiculite. The subsections are arranged as follows: 
1) section 3.3.1 presents the first pleural thickening measurement method that measures the 
sampled distances between ribs and pleural surface; 
2) section 3.3.2 presents the second pleural thickening measurement method that measures the 
volume of concave regions on the pleural surface; 
3) section 3.3.3 describes experiments and evaluation method and section 3.3.4 gives the 
corresponding results; 
4) section 3.3.5 and 3.3.6 presents discussion and conclusion. 
3.3.1    Measurement using distance between pleural surface and ribs 
Distance between ribs and pleural surface is used as a surrogate measurement to the 
actual pleural thickness for two reasons: first, in early-stage pleural thickening cases, the 
abnormal region is very small and subtle and it may be difficult to measure them directly; 
second, it is observed that early-stage pleural thickening cases usually have an overall increased 
distance between pleural surface and ribs due to pleural abnormality (see Figure 3.14). 
Therefore, instead of trying to directly capture small abnormal regions, the overall distances are 
measured. The algorithm first obtains the evenly sampled minimum distances between pleural 
surface and ribs. Then samples in unreliable regions are eliminated where there is likely to be a 
large space between ribs and pleural surface due to natural anatomical structures. The algorithm 
is listed in Algorithm 3.3. 
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Figure 3.14: Pleural thickening in two cases outlined by a radiologist (yellow), both of which 
manifest as an enlarged distance between the rib and the pleural surface. 
 
Algorithm 3.3 Distance measurement between ribs and lungs 
1) Obtain segmented ribs and lungs using a previously published method (Lee et al. 2010) 
[48] (see Figure 3.15) and cast image rays axially from lung center towards pleural surface; 
2) Retain rays that intersect with a rib and denote the distance between the intersection point 
and pleural surface as Rijk, where i is the CT slice number, j is the ray angle ([0°, 360°] 
with a step size of 4°), and k is the rib label (see Figure 3.16); 
3) For each k at each j, select the ray Rajk that minimizes the distance as shown in Figure 3.17: R´µ¶ = min 𝑅R·Y , 𝑖 ∈ [1, 𝑛]                                                                                             (2.5) 
4) Exclude measurements in the most superior section of each lung, adjacent to vertebrae, or 
in the most inferior left lung close to the diaphragm (see Figure 3.18 for exclusion 
examples); 
5) Obtain the remaining distance measurements as shown in Figure 3.19 and compute their 
statistics: mean Dmean and standard deviation Dsdev. 
 
 
 
 
                (a)                                (b)                              (c) 
Figure 3.15: Visualization of segmented and labeled ribs and lungs. (a) coronal view of labeled 
ribs in different colors, (b) coronal view of the segmented lungs; (c) both ribs and lungs in an 
axial slice overlaid on an intensity image in different colors. 
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Figure 3.16: Ray casting model. Image rays intersecting with a rib are shown in solid blue lines 
while other rays are in dashed lines. Lungs are in different shades of pink and ribs are colored 
individually. Image slice (i), rib label (k) and angle j are also shown. 
 
Figure 3.17: Demonstration of ray selection. Among the three rays intersecting with rib k at 
angle j, only the ray with the minimum distance is selected. 
 
                      (a)                                           (b)                                    (c) 
Figure 3.18: Examples of excluded distance measurements. Red circles indicate the general 
regions and green circles indicate the excluded measurements (radius of the circle is the actual 
distance). (a) exclusion in the superior lung and vertebrae adjacent regions; (b) exclusion in the 
vertebrae adjacent regions; (c) exclusion in the inferior left lung close to the diaphragm. 
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                      (a)                                                                (b) 
Figure 3.19: Visualization of final distance measurements in red circles. (a) and (b) show their 
locations relative to the ribs and lungs in coronal and axial views. 
3.3.2    Measurement using concave regions on the pleural surface 
 While the first method in section 3.3.1 focuses on the overall increase of distances 
between pleural surface and ribs, this method measures pleural thickening by detecting and 
extracting concave regions on the pleural surface. This method is designed to capture the more 
visible pleural thickening that causes a measureable concavity on the pleural surface (see Figure 
3.20 (a)). The algorithm is listed in Algorithm 3.4. It first detects and measures the concave 
region volume using a surface tracing and convex hull method. Then within all the concave 
regions, a subset of regions not adjacent to ribs is extracted and their volume also measured. This 
is to avoid the natural pleural surface indentation caused by the ribs. Both volume measurements 
are used in evaluation. 
 
Algorithm 3.4 Concavity measurement on the pleural surface 
1) Trace the costal pleural surface on the segmented lung from anterior to posterior (see 
Figure 3.20 (b)-(c)); 
2) Compute a convex hull on the traced costal surface; 
3) The differences before and after the convex hull operation are considered to be the concave 
regions as shown in Figure 3.20 (d); 
4) Extract concave region pixels within the soft tissue intensity range and compute their 
volume as VolA; 
5) Exclude concave regions less than 5mm from the segmented ribs and re-compute their 
volume VolS. 
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                   (a)                                   (b)                                (c)                                  (d) 
Figure 3.20: Extraction of a concave region on the pleural surface. (a) target concave region; (b) 
traced pleural surface in a red line; (c) a zoomed-in concave region in (b) (yellow outlined); (d) 
detected concavity (region bounded by blue and red lines). 
3.3.3    Experiments and evaluation 
The evaluation dataset consists of 100 chest CT scans of subjects exposed to Libby 
vermiculite. The scans are from different subjects, non-contrast and have a slice thickness of 
1.25mm or less. The lung region in each scan is partitioned into 6 subsections: Left Upper lung 
(LU), Left Middle lung (LM), Left Lower lung (LL), Right Upper lung (RU), Right Middle lung 
(RM) and Right Lower lung (RL), where LU, LM and LL are the superior, middle and lower 
lung regions with equal volume and the same applies to RU, RM and RL. The two pleural 
thickness measurements are performed in the 6 subsections as well as in each lung. Each 
subsection has a visual rating by a radiologist. The rating ranges from 1 to 4 and the higher the 
rating is, the more severe pleural thickening in that subsection is. A rating of 1 indicates no or 
minimal abnormality. 
Two experiments are performed: the first experiment evaluates the agreement between 
the computer measurements with the visual ratings by each subsection and the second 
experiment evaluates the agreement by each lung, in which the median rating of the 3 
subsections of each lung is chosen to be the rating of that lung. Both Pearson correlation 
coefficient R and Spearman correlation coefficient R are computed in the two experiments. 
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3.3.4    Results 
 Results from the two experiments are summarized in Tables 3.8-3.9. The visual 
inspection statistics is summarized in Table 3.10. Method 1 is the pleural surface and ribs 
distance measurement and Method 2 is the concavity volume measurement. Experiment 1 
evaluates the agreement by subsection and Experiment 2 evaluates the agreement by each lung. 
Table 3.8. Pearson R from pleural thickening experiments. 
Pearson R Method 1 Method 2 
 Dmean Dsdev VolA VolS 
Experiment 1 0.32 0.35 0.60 0.60 
Experiment 2 0.33 0.40 0.69 0.74 
 
Table 3.9. Spearman R from pleural thickening experiments. 
Spearman R Method 1 Method 2 
 Dmean Dsdev VolA VolS 
Experiment 1 0.21 0.23 0.33 0.35 
Experiment 2 0.21 0.24 0.37 0.36 
 
Table 3.10. Visual inspection statistics (mean, median and standard deviation) for each 
subsection, each lung and the two lungs. 
Location Mean Median Standard deviation 
LU 1.29 1 0.66 
LM 1.31 1 0.71 
LL 1.23 1 0.63 
RU 1.39 1 0.85 
RM 1.36 1 0.79 
RL 1.24 1 0.62 
Left lung 1.28 1 0.66 
Right lung 1.33 1 0.76 
Lungs 1.30 1 0.71 
 
3.3.5    Discussion 
 In both experiment 1 and 2, method 2 (volume of concave regions) has higher agreement 
with visual ratings than method 1. However, neither method has shown a strong correlation with 
visual ratings. It should be noted that method 2 targets regions more visible to human observers 
while it is difficult for observers to identify the subtle changes targeted by method 1. Therefore 
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method 2 is likely to have a higher agreement with human observers. Another potential reason 
for the overall low agreement is that the majority of the cases have minimal visually detectable 
pleural thickening as shown in Table 3.10. Therefore without the information of patients’ 
medical history or clinical diagnostic outcome, it is difficult to judge whether the computer 
algorithms are measuring anything useful for diagnosis in these early-stage pleural thickening 
cases. 
 Overall, both methods are able to correctly capture many abnormal regions (see Figure 
3.21 upper row). However, a common false positive for both methods is the large distance or 
indentation caused by ribs (see Figure 3.21 lower row). These regions have no visual difference 
compared to the true pleural thickening regions and cannot be reliably excluded by the current 
methods. 
    
                                 (a)                                                                   (b) 
    
                                      (c)                                                                   (d) 
Figure 3.21: Correctly identified pleural thickening regions (upper row) and normal regions 
incorrectly identified as pleural thickening (lower row). (a) and (c) are identified by method 1 
(red circles); (b) and (d) are identified by method 2 (blue regions). 
 In addition, neither method is designed to capture the pleural thickening adjacent to the 
vertebrae since both methods explicitly exclude measurements in this region. This exclusion is 
  84 
performed because the pleural surface adjacent to the vertebrae has a very similar appearance to 
the real pleural thickening regions such as a large indentation and a large space between pleural 
surface and ribs (see Figure 3.22). More advanced algorithm is needed to measure pleural 
thickening in this region. 
      
                     (a)                                                (b) 
Figure 3.22: Pleural surface regions adjacent to vertebrae in two cases with similar visual 
presentations. (a) pleural thickening; (b) normal (through visual rating). 
3.3.6    Conclusion 
 In conclusion, two fully automated computer methods have been designed to detect early-
stage pleural thickening by measuring the pleural surface to rib distances and the volume of 
pleural surface concave regions. Evaluated on a cohort of subjects exposed to Libby vermiculite, 
both methods show some correlation with visual ratings with the concavity measurement having 
higher correlation (Pearson R=0.75 and Spearman R=0.36). To evaluate the potentials of the 
algorithms, a much larger dataset with documented clinical diagnostic outcomes is needed.
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CHAPTER 4 
 
IMAGE QUALITY MEASUREMENT 
 The image quality (noise and calibration) of a CT scan has a direct impact on the 
performance of CAD algorithms. Noise impacts the detectability of image biomarkers. For 
instance, in Chapter 2 it has been shown that the detectability of CAC significantly decreases 
when the heart region noise level increases from below to over 110HU. Calibration impacts 
thresholding based algorithms and biomarker measurements. For example, one of the most 
common emphysema measurements, emphysema index, is defined to be the fractional pixels in 
the lung region below the intensity threshold of -950HU. Therefore, this index will be inaccurate 
if the CT scan is not properly calibrated. Image quality can also impact the visual reading 
precisions of a CT scan by human observers.  
In this dissertation, a fully-automated method to evaluate CT image quality is presented. 
It takes advantage of the pre-segmented regions such as the aorta and is a natural extension of the 
previously developed CAD algorithms in Chapters 2-3. In the following sections, section 4.1 
describes the automated extraction of regions used for quality measurement; section 4.2 
describes the evaluation methods and the evaluation datasets for the automated quality 
measurement; section 4.3 gives the evaluation results; section 4.4 and section 4.5 gives the 
discussion and conclusion. 
4.1    Extraction of quality measurement regions 
 The image quality measurement described in this dissertation includes the measurement 
of noise and calibration. They are both obtained from 3D homogeneous regions. Noise is 
represented as the pixel standard deviation of a homogeneous region and calibration is 
represented as the mean pixel intensity of a homogeneous region. 
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 Previous studies in other research groups have measured noise or calibration using 
manually defined regions such as manually drawn circular regions inside the DA and the trachea 
lumen (Singh et al. 2011, Ohno et al. 2012, Yamada et al. 2012) [41-43]. In this dissertation, the 
measurement regions are obtained based on pre-segmented regions such as the aorta and the 
trachea. In total, three homogeneous regions are obtained for the purpose of quality 
measurement: an external air region (EA), the trachea lumen region (TA), and the DA lumen 
blood region (AB). The extractions of the 3D homogeneous regions are described below. 
4.1.1    Extraction of the EA region 
 The external air region is defined to be anterior to and outside the body. It lies within the 
image reconstruction circle with the same vertical extent of the lungs. This is a very 
homogeneous air region in majority of the cases. However, occasionally artifacts such as 
clothing can affect the homogeneity in this region (see Figure 4.1). To avoid this issue, the 
algorithm described in Algorithm 4.1 is used to extract a maximized homogeneous EA region. 
           
                      (a)                                                       (b) 
Figure 4.1: Example EA regions in two cases (indicated by the red arrows). (a) a homogeneous 
EA region; (b) EA region with artifacts. 
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Algorithm 4.1 Extraction of EA region 
1) Identify air pixels in the pre-segmented external body region through median image 
filtering and intensity thresholding at -600HU; 
2) Fit the largest possible elliptical cylinder into this air region (see Figure 4.2); 
3) If the elliptical cylinder does not meet the minimum size requirement (a cross sectional 
dimension of 20mm´10mm), use a fixed size ellipse (20mm´10mm) in image slice where 
this ellipse will fit in. 
 
 
 
                      (a)                                           (b) 
Figure 4.2: Visualization of an extracted EA region. (a) EA in red in an axial slice; (b) EA in red 
in a sagittal view together with the lungs (light pink) and the bones (light grey). 
4.1.2    Extraction of the TA region 
 Trachea region can be obtained from the segmented airway using a previously developed 
algorithm (Lee et al. 2009) [45]. Only the trachea region within the extent of the lungs is used. 
The trachea mask is eroded with a small kernel (circle with a diameter of 5mm) to avoid the 
boundary transition region. The extracted TA region is shown in Figure 4.3. 
                     
                (a)                                       (b)                                     (c) 
Figure 4.3: Visualization of an extracted TA region. (a) segmented trachea in green together with 
the lungs (light pink) and the bones (light grey) in a coronal view; (b) segmented trachea in green 
in an axial slice; (c) TA region after erosion. 
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4.1.3    Extraction of the AB region 
 The DA is obtained from the segmented aorta. It starts at the carina level and ends at the 
top of the lung diaphragm (i.e. the end of the segmented DA). The DA is also eroded with a 
small kernel (circle with a diameter of 7mm) to avoid boundary transition region. The extracted 
DA lumen region AB is shown in Figure 4.4. 
                     
               (a)                                           (b)                                         (c) 
Figure 4.4: Visualization of an extracted AB region. (a) segmented DA in blue together with the 
lungs (light pink) and the bones (light grey) in a coronal view; (b) segmented DA in blue in an 
axial slice; (c) AB region after erosion. 
4.1.4    Quality measurement using EA, TA, and AB 
 Noise and calibration are measured from the three extracted homogeneous regions in two 
different ways. First, the global noise and calibration values are reported, i.e. the standard 
deviation and mean of all pixels within the EA, TA and AB regions (see Figure 4.5). Second, the 
noise and calibration values are reported in each image slice, resulting in a quality measurement 
profile as shown in Figure 4.6. 
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Figure 4.5: Three homogeneous regions shown in a sagittal view. EA (red), TA (green), and AB 
(blue) are shown together with the lungs (light pink). For visualization purpose, TA and AB are 
not eroded.  
 
                                     (a)                                                                     (b) 
Figure 4.6: Noise and calibration profiles along the image slices. (a) noise profiles where EA 
profile is in red, TA in green and AB in blue; (b) calibration profiles with the same color 
schemes. For plotting purpose, 1000HU has been deducted from AB calibration values. 
4.2    Evaluation methods and datasets 
 The automated algorithm is first evaluated on phantom CT datasets to assess its 
repeatability and sensitivity. Then it is evaluated on a cohort of LCS LDCT) scans. Section 4.2.1 
defines the experiments using the phantom data and section 4.2.2 defines the experiments using 
the LDCT data. All LDCT scans selected for evaluation have acceptable cardiac and airway 
segmentations using visual inspection to ensure the quality of the AB and TA measurement. For 
EA segmentation, the mask region spans a minimum of 10 image slices. 
 The primary image quality measurements are: noise and calibration in the EA, TA, AB 
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regions. Noise in the three regions is denoted as En, Tn, and An. Calibration in the three regions 
is denoted as Ec, Tc, and Ac. For a group of scans, statistics of the group measurement is used 
for quality characterization. For instance, the mean and standard deviation of En from all scans 
in the group is denoted as µEn and sEn, which are used to characterize the EA noise properties of 
the group. 
 In addition to the global noise and calibration measurements, the per-slice image quality 
profile is also employed to analyze groups of CT scans. For each group, an average quality 
profile is computed by performing a linear interpolation on the per-slice measurement from each 
individual scan. The profiles are interpolated to the same length (1000 sample points) and 
averaged to obtain the average quality profile. The standard deviation at each interpolated point 
is also computed and plotted together with the average. 
4.2.1    Phantom experiments 
 The image quality measurements are performed on CT scans acquired using a chest 
anthropomorphic phantom [88-90]. The phantom was used in an FDA study to evaluate lung 
nodule size estimation and contains a vasculature insert on which synthetic nodules were inserted 
or attached. Each unique positioning of the nodules is referred to as a nodule layout. It also 
contains a trachea and bone structures. It does not contain an aorta. 
 The phantom was scanned using a Philips 16-row scanner (Mx8000 IDT) and a Siemens 
64-row scanner (Somatom Definition 64). Scans were acquired with varying combinations of 
effective dose (mAs), pitch, and slice collimation, and reconstructed with varying combinations 
of slice thicknesses and reconstruction kernels.	Ten repeat scans have been collected for each 
imaging protocol (acquisition and reconstruction) and each nodule layout.	For the 10 repeat 
scans, the phantom position was not changed; however, it was repositioned between different 
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imaging protocols or different nodule layouts. 
 In the current public dataset released for this study, there are 4 datasets corresponding to 
4 different nodule layouts. Three of the datasets were acquired using Philips and the fourth 
acquired using Siemens. The Philips scans had the following imaging protocols: four different 
effective dose (20 or 25mAs, 50mAs, 100mAs, 200mAs), slice collimation 16´0.75mm, slice 
overlap of 50%, two different pitches (0.9 and 1.2), two different reconstruction filters (B and C), 
multiple slice thicknesses (0.8mm, 1.5mm, 2mm, 3mm, 5mm). The corresponding z image 
resolution (zres) is 0.4mm, 0.7mm, 1mm, 1.5mm, 2.5mm. The Siemens scans had the following 
imaging protocols: three different effective dose (25mAs, 100mAs, 200mAs), slice collimation 
64´0.6mm, two different overlaps (0% and 50%), two different pitches (0.9 and 1.2), two 
different reconstruction filters (B40f and B60f), multiple slice thicknesses (0.75mm, 1.5mm, 
3mm). The corresponding zres is 0.4mm, 0.7mm, 1.5mm (with overlap) and 0.7mm, 1.5mm, 
3mm (no overlap). 
Our automated algorithms were able to reliably segment the EA and TA regions in most 
phantom images. Since DA is not represented in the phantom, image quality is only measured in 
EA and TA regions using cases where these two regions have been correctly segmented. Four 
different experiments are performed. The first experiment evaluates the algorithms’ repeatability 
between longitudinal scan pairs with the same imaging protocol. The next three experiments 
evaluate the sensitivity of the algorithms to the change of imaging protocols including the 
radiation exposure levels, slice thicknesses and reconstruction filters; The sensitivity experiments 
are evaluated separately on a set of Philips scans and a set of Siemens scans. Table 4.1-4.4 list 
the dataset description for the four experiments. 
The first experiment	studies the repeatability of the measurements between longitudinal 
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scan pairs with the same imaging protocols. In this study, 26 longitudinal scan pairs are selected. 
For each pair, the two scans have the same imaging protocol but were taken at different times 
(T1 and T2). The time interval between T1 and T2 ranges from 4 to 7 months. The imaging 
protocol of each pair is summarized in Table 4.1. The hypothesis is that the algorithm should 
have minimum differences in all measurements between longitudinal scan pairs. 
For this experiment, the statistics of the differences in each quality measurement is 
reported. There are 4 differences: differences in EA noise DEn, TA noise DTn, EA calibration 
DEc, and TA calibration DTc. Each difference is computed by subtracting T2 measurement from 
T1 measurement. The minimum, maximum, mean, median and standard deviation of the 26 
differences are reported. 
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Table 4.1. Datasets summary for the longitudinal scan pairs in phantom repeatability experiment. 
pair slice (mm) zres (mm) mAs pitch collimation recon 
1 0.8 0.4 200 0.9 0.75 C 
2 1.5 0.7 200 0.9 0.75 C 
3 3 1.5 200 0.9 0.75 C 
4 2 1 25 0.9 1.5 C 
5 3 1.5 25 0.9 1.5 C 
6 5 2.5 25 0.9 1.5 C 
7 1.5 0.7 100 0.9 0.75 C 
8 3 1.5 100 0.9 0.75 C 
9 2 1 100 0.9 1.5 C 
10 3 1.5 100 0.9 1.5 C 
11 5 2.5 100 0.9 1.5 C 
12 2 1 200 0.9 1.5 C 
13 3 1.5 200 0.9 1.5 C 
14 5 2.5 200 0.9 1.5 C 
15 2 1 200 1.2 1.5 C 
16 3 1.5 200 1.2 1.5 C 
17 5 2.5 200 1.2 1.5 C 
18 0.8 0.4 25 0.9 0.75 C 
19 3 1.5 25 0.9 0.75 C 
20 1.5 0.7 200 1.2 0.75 C 
21 3 1.5 200 1.2 0.75 C 
22 1.5 0.7 100 1.2 0.75 C 
23 3 1.5 100 1.2 0.75 C 
24 2 1 100 1.2 1.5 C 
25 3 1.5 100 1.2 1.5 C 
26 5 2.5 100 1.2 1.5 C 
 
The second experiment compares the quality measurement between scans of the same 
imaging protocol except for radiation exposure level (mAs). The hypothesis is that a higher mAs 
will lead to a decreased noise level while the variations of mAs should have a minimum impact 
on calibration. In this experiment, for each unique combination of imaging protocols, statistics of 
the quality measurements are given for groups of repeated scans. In addition, for the lowest and 
highest radiation groups, the average quality profiles along the image slices are also computed. 
Dataset for this experiment is summarized in Table 4.2. 
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Table 4.2. Datasets summary for phantom sensitivity experiment: change of radiation exposure 
(mAs). 
Scanner Number of scans (exposure) Other parameters 
Philips Group1: 10 (25mAs) 
Group2: 10 (50mAs) 
Group3: 10 (100mAs) 
Group4: 4 (200mAs) 
Slice thickness=0.8mm 
zres=0.4mm 
Pitch=0.9 
Collimation=0.75mm 
Recon filter=C 
Siemens Group1: 10 (25mAs) 
Group2: 10 (100mAs) 
Group3: 10 (200mAs) 
Slice thickness=0.75mm 
zres=0.7mm 
Pitch=0.9 
Collimation=0.6mm 
Recon filter=B40f 
 
The third experiment compares the quality measurement between scans of the same 
imaging protocol except for reconstruction slice thicknesses. The hypothesis is that a thicker 
slice thickness will lead to a decreased noise level while the variations of slice thicknesses 
should have a minimum impact on calibration. In this experiment, for each unique combination 
of imaging protocols, statistics of the quality measurements are given for groups of repeated 
scans. Dataset for this experiment is summarized in Table 4.3. 
Table 4.3. Datasets summary for phantom sensitivity experiment: change of slice thickness. 
Scanner Number of scans  
(slice thickness, zres) 
Other parameters 
Philips Group1: 9 (0.8mm, 0.4mm) 
Group2: 10 (1.5mm, 0.7mm) 
Group3: 9 (3mm, 1.5mm) 
Effective dose=25mAs 
Pitch=0.9 
Collimation=0.75mm 
Recon filter=C 
Siemens Group1: 10 (0.75mm, 0.4mm) 
Group2: 9 (1.5mm, 0.7mm) 
Group3: 10 (3mm, 1.5mm) 
Effective dose=25mAs 
Pitch=0.9 
Collimation=0.6mm 
Recon filter=B40f 
 
The fourth experiment compares the quality measurement between scans of the same 
imaging protocol except for reconstruction filter type. The hypothesis is that a more enhanced 
reconstruction filter will lead to an increased noise level while the variations of reconstruction 
filters should have a minimum impact on calibration. In this experiment, for each unique 
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combination of imaging protocols, statistics of the quality measurements are given for groups of 
repeated scans. Dataset for this experiment is summarized in Table 4.4. 
Table 4.4. Datasets summary for phantom sensitivity experiment: change of reconstruction filter. 
Scanner Number of scans  
(recon filter) 
Other parameters 
Philips Group1: 5 (B) 
Group2: 10 (C) 
Slice thickness=2mm 
zres=1mm  
Effective dose=25mAs 
Pitch=0.9 
Collimation=1.5mm 
Siemens Group1: 10 (B40f) 
Group2: 9 (B60f) 
Slice thickness=0.75mm 
zres=0.7mm 
Effective dose=25mAs 
Pitch=0.9 
Collimation=0.6mm 
  
4.2.2    LDCT experiments 
Studies from a LCS cohort [73] were used retrospectively to evaluate the repeatability of 
the quality measures and the impact on quality of different CT parameter settings. Four 
experiments are performed to assess the repeatability and sensitivity of the measurements. 
Description of the datasets and experiments are given below. 
 The first experiment evaluates the algorithm repeatability using longitudinal scan pairs 
with consistent imaging protocols. It is evaluated on 31 pairs of longitudinal scans. All scans in 
this experiment were acquired using Siemens Somatom Definition Flash scanner model and 
reconstructed using I41f\4 filter and at a slice thickness of 0.5mm without overlapping. They 
were acquired with a kVp of 120 and an mA of 48. The time interval between the pairs ranges 
from 84 to 438 days (median 369 days). 
For this experiment, the statistics of the differences in each quality measurement is 
reported. There are 6 differences: differences in EA noise DEn, TA noise DTn, AB noise DAn, 
EA calibration DEc, TA calibration DTc, and AB calibration DAc. Each difference is computed 
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by subtracting T2 measurement from T1 measurement. The minimum, maximum, mean, median 
and standard deviation of the 31 differences are reported. 
The second experiment compares the quality measurement between scans of the same 
imaging protocol except for reconstruction filter type. It follows the same hypothesis of the 
phantom experiment three (a more enhanced reconstruction filter leads to an increased noise 
level while having a minimum impact on calibration). However, more variations are expected 
compared to the phantom experiment. In this experiment, for each unique combination of 
imaging protocols, statistics of the quality measurements are given for groups of scans with the 
same reconstruction filter. The datasets are listed in Table 4.5. 
Table 4.5. Datasets summary for LDCT sensitivity experiment: change of reconstruction filter. 
Scanner Number of scans  
(recon filter) 
Other parameters 
GE (Medical Systems Discovery CT750 
HD) 
Group1: 74 (Standard) 
Group2: 74 (Bone) 
Slice thickness=0.625mm 
zres=0.625mm  
Exposure=120kVp, 30mA 
Siemens (Biograph 40) Group1: 160 (B40f) 
Group2: 160 (B60f) 
Slice thickness=1mm 
zres=1mm 
Exposure=120kVp, 48mA 
 
 The third experiment also compares the quality measurements between different 
reconstruction filter types. The average quality profiles for each reconstruction filter type are 
plotted. This experiment is evaluated on four datasets, two of which have also been used in the 
first experiment (Siemens B40f and B60f). The other two datasets are: a group of scans acquired 
using dose-modulation and reconstructed with the iterative reconstruction filter; a group of scans 
reconstructed with the iterative reconstruction filter without dose-modulation. The hypothesis is 
that the average quality profiles will have different trends for all four reconstruction filters. 
Details of the four datasets are given in Table 4.6. 
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Table 4.6. Datasets summary for LDCT sensitivity experiment: change of reconstruction filter 
using image profiles. 
Scanner + Recon Filter Number of scans  Other parameters 
Siemens (Biograph 40) + B40f 160 Slice thickness=1mm 
zres=1mm 
Exposure=120kVp, 48mA 
Siemens (Biograph 60) + B60f 160 Slice thickness=1mm 
zres=1mm 
Exposure=120kVp, 48mA 
Siemens (Somatom Definition Flash) + 
I41f\4 + dose-modulation 
9 Slice thickness=0.5mm 
zres=0.5mm 
Exposure=120kVp, various mA  
Siemens (Somatom Definition Flash) + 
I41f\4 
160 Slice thickness=0.5mm 
zres=0.5mm 
Exposure=120kVp, 48mA 
  
 The fourth experiment evaluates the general statistics on quality measurements on a large 
LCS dataset with 841 scans. They consist of 544 GE scans (Discovery CT750 HD and 
LightSpeed VCT, 120kVp, 30 or 40 mA) with Standard reconstruction filters and 297 Siemens 
scans (Biograph40 and Sensation Cardiac 64, 120kVp, 48 or 60 mA) with B40f reconstruction 
filters. All scans have a slice thickness of 1.25mm or less. Histograms of the six quality 
measurements (En, Tn, An, Ec, Tc, Ac) are plotted. 
4.3    Results 
 Results of the phantom and LDCT experiments are reported in this section: section 4.3.1 
reports the phantom experiment results and section 4.3.2 reports the LDCT experiment results. 
4.3.1    Phantom experiment results 
Results of the first phantom experiment (repeatability between longitudinal scan pairs) are 
summarized in Table 4.7. Results of the second phantom experiment (change in radiation 
exposure) are given in Table 4.8 and Figures 4.7-4.9. Figures 4.7-4.8 show the average quality 
profiles for the lowest and highest radiation exposure settings. Results of the third and fourth 
phantom experiments (change in slice thickness and change in reconstruction filter) are given in 
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Tables 4.9-4.10. Figure 4.9 summarizes the phantom sensitivity experiment results in Tables 4.8-
4.10. 
Table 4.7. Phantom repeatability experiment results: statistics of the differences (HU) in image 
quality between longitudinal scan pairs. 
 min max mean sdev median 
DEn -1.03 0.04 -0.18 0.25 -0.11 
DTn -2.18 1.24 -0.45 1.02 -0.54 
DEc -1.40 0.09 -0.22 0.36 -0.13 
DTc -3.54 1.55 0.46 1.18 0.84 
 
Table 4.8. Phantom sensitivity experiment results: change in radiation exposure. 
Scanner mAs µEn (sEn) µTn (sTn) µEc (sEc) µTc (sTc) 
Philip 25 16.11 (0.05) 55.39 (0.47) -988.80 (0.04) -887.47 (1.41) 
50 11.45 (0.03) 45.89 (0.74) -991.70 (0.03) -875.97 (0.70) 
100 8.34 (0.02) 34.35 (0.44) -993.78 (0.01) -878.30 (0.53) 
200 6.21 (0.01) 25.30 (0.15) -995.22 (0.01) -878.86 (0.28) 
Siemens 25 19.43 (0.04) 54.39 (1.67) -995.73 (0.02) -894.85 (0.61) 
100 11.46 (0.03) 29.07 (0.14) -999.71 (0.02) -896.34 (0.32) 
200 8.71 (0.02) 22.01 (0.14) -1000.16 (0.03) -895.76 (0.19) 
 
Table 4.9. Phantom sensitivity experiment results: change in slice thickness. 
Scanner zres µEn (sEn) µTn (sTn) µEc (sEc) µTc (sTc) 
Philips 0.4 16.16 (0.04) 55.16 (0.56) -988.81 (0.04) -887.22 (1.72) 
0.7 11.00 (0.03) 42.79 (0.68) -992.20 (0.03) -889.40 (1.27) 
1.5 8.12 (0.03) 35.37 (0.74) -994.09 (0.02) -891.39 (2.55) 
Siemens 0.4 19.44 (0.04) 54.37 (0.95) -995.72 (0.02) -894.79 (0.54) 
0.7 14.28 (0.03) 38.39 (0.98) -998.26 (0.02) -895.42 (0.42) 
1.5 11.05 (0.02) 29.41 (0.83) -999.71 (0.02) -895.45 (0.45) 
 
Table 4.10. Phantom sensitivity experiment results: change in reconstruction filter. 
Scanner Recon µEn (sEn) µTn (sTn) µEc (sEc) µTc (sTc) 
Philips B 7.07 (0.02) 30.81 (0.51) -995.31 (0.02) -874.05 (0.62) 
C 9.19 (0.03) 40.39 (0.76) -993.92 (0.01) -874.27 (0.95) 
Siemens B40f 19.43 (0.04) 54.39 (1.67) -995.73 (0.02) -894.85 (0.61) 
B60f 78.77 (0.16) 166.30 (2.87) -949.78 (0.06) -833.10 (2.79) 
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                    (a) Philip noise (25mAs)                               (b) Siemens noise (25mAs)     
   
                   (c) Philip noise (200mAs)                              (d) Siemens noise (200mAs)                          
Figure 4.7: Average noise profiles from phantom sensitivity experiment: change of mAs (lowest 
and highest mAs shown). (a) Philip cohort (25mAs); (b) Siemens cohort (25mAs); (c) Philip 
cohort (200mAs); (d) Siemens cohort (200mAs). 
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             (a) Philip calibration (25mAs)                        (b) Siemens calibration (25mAs) 
 
            (c) Philip calibration (200mAs)                       (d) Siemens calibration (200mAs) 
Figure 4.8: Average calibration profiles from phantom sensitivity experiment: change of mAs 
(lowest and highest mAs shown). (a) Philip cohort (25mAs); (b) Siemens cohort (25mAs); (c) 
Philip cohort (200mAs); (d) Siemens cohort (200mAs). 
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                                              (a) Philips noise 
 
                                            (b) Siemens noise 
 
                                            (c) Philips calibration 
 
                                           (d) Siemens calibration 
Figure 4.9: Summary plot for phantom sensitivity experiments. (a) Philips cohort noise; (b) 
Siemens cohort noise; (c) Philips cohort calibration; (d) Siemens cohort calibration. 
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4.3.2    LDCT experiment results 
Results of the first LDCT experiment (repeatability between longitudinal scan pairs) are 
summarized in Table 4.11. Results of the second and third LDCT experiment (change in 
reconstruction filter) are given in Table 4.12 and Figures 4.10-4.12. Figure 4.10 shows the 
statistics for each imaging protocol. The plots are grouped together based on scanner types. 
Figures 4.11-4.12 show the average quality profiles for the four datasets. Results of the fourth 
LDCT experiment (histogram statistics on a large LCS cohort) are shown in Figure 4.13 and 
Table 4.13. 
Table 4.11. LDCT repeatability experiment results: statistics of the differences (HU) in image 
quality between longitudinal scan pairs. 
 min max mean sdev median 
DEn -48.44 9.28 -4.40 11.18 -1.42 
DTn -5.29 4.44 -1.62 2.58 -2.25 
DAn -5.48 4.08 -1.01 2.59 -0.81 
DEc -31.03 17.12 0.21 9.55 1.74 
DTc -9.82 30.05 4.92 9.58 2.16 
DAc -7.85 5.16 -1.27 2.73 -0.81 
 
Table 4.12. LDCT sensitivity experiment results: change in reconstruction filter. 
Scanner GE Siemens 
Recon Standard Bone B40f B60f 
µEn (sEn) 24.61 (9.60) 47.07 (11.52) 21.44 (7.32) 70.32 (13.57) 
µTn (sTn) 43.74 (7.94) 89.91 (15.65) 31.20 (5.27) 97.28 (14.42) 
µAn (sAn) 44.53 (9.64) 106.99 (23.64) 38.45 (9.13) 162.58 (33.76) 
µEc (sEc) -995.53 (6.17) -984.60 (7.26) -992.33 (4.64) -946.81 (12.41) 
µTc (sTc) -952.36 (10.19) -936.78 (13.11) -980.97 (6.27) -911.37 (18.17) 
µAc (sAc) 32.00 (7.23) 31.99 (7.00) 40.22 (3.15) 38.63 (3.45) 
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                         (a) GE noise                                      (b) Siemens noise 
 
                   (c) GE calibration                               (d) Siemens calibration 
Figure 4.10: Summary bar plot showing mean and standard deviation for the LDCT sensitivity 
experiment. (a) GE cohort noise; (b) Siemens cohort noise; (c) GE cohort calibration; (d) 
Siemens cohort calibration. 
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                   (a) Dose-modulated I41f\4                                   (b) Regular I41f\4 
 
 
                                (c) B40f                                                           (d) B60f 
Figure 4.11: Average noise profiles from LDCT sensitivity experiment. 
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                   (a) Dose-modulated I41f\4                                    (b) Regular I41f\4 
 
                                (c) B40f                                                           (d) B60f 
Figure 4.12: Average calibration profiles from LDCT sensitivity experiment. 
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                             (a) En                                                      (b) Ec 
 
 
                             (c) Tn                                                      (d) Tc 
 
 
                             (e) An                                                      (f) Ac 
Figure 4.13: Noise and calibration histograms for the LCS cohort. (a) En; (b) Ec; (c) Tn; (d) Tc; 
(e) An; (f) Ac.  
Table 4.13. LDCT experiment results: statistics of quality on a LCS cohort (841 scans). 
Measure Min  Max  Mean Standard deviation  
En 9.22 87.40 23.17 8.35 
Tn 17.60 118.60 39.41 11.42 
An 15.45 171.50 42.07 15.55 
Ec -1006.0 -949.6 -995.2 4.68 
Tc -994.8 -881.3 -959.0 18.63 
Ac 8.50 62.53 34.11 7.74 
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4.4    Discussion 
 The automated CT image quality assessment algorithm has shown good repeatability and 
sensitivity in both phantom and LDCT experiments. In the phantom repeatability experiment, the 
largest standard deviation among all 4 types of differences (DEn, DTn, DEc, DTc) is 1.18HU as 
shown in Table 4.7, which indicates that under ideal situations, these quality measurements are 
very repeatable. In the LDCT repeatability experiment, the largest standard deviation among all 
6 types of differences (DEn, DTn, DAn, DEc, DTc, DAc) is 11.18HU as shown in Table 4.11, 
larger than that from the phantom experiment. It should also be noted that the AB repeatability is 
the highest among the three regions in the LDCT experiment (standard deviation of 2.59HU for 
DAn and 2.73HU for DAc). 
 In the phantom sensitivity experiment, the noise measurement has exhibited expected 
changes regarding the changes in imaging protocols. For instance, when radiation exposure or 
slice thickness increases, the noise level in both EA and TA decreases; images reconstructed 
with a more enhanced filter type (B60f, C) have higher noise than those reconstructed with a less 
enhanced filter (B40f, B). The noise measurement has displayed similar characteristics in the 
LDCT sensitivity experiment, i.e. the Bone reconstruction filter corresponds to a higher noise 
level than the Standard filter and the B60f filter higher than the B40f filter. 
 In the phantom experiments, the calibration measurement has displayed a small change 
(in the order of 5HU) regarding the changes in radiation exposure and slice thickness. The 
calibration measurement has a small change between reconstruction filter B and C (less than 
5HU) but has a larger change between reconstruction filter B40f and B60f (in the order of 
50HU). This characteristic has also been displayed in the LDCT experiment: calibration in the 
air regions has a large change between B40f and B60f (in the order of 50HU) and a relatively 
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large change between Standard and Bone (in the order of 20HU). However, calibration in AB is 
more stable and the change between reconstruction filters is around 2HU. 
 The averaged group quality profile differs with imaging protocols. In the phantom 
experiment, the most significant difference occurs in the upper trachea region. In the LDCT 
experiment, the four different reconstruction filters correspond to distinctively different profiles. 
The profiles from the dose-modulated scans appear the most stable and have small variations 
across spatial locations. The profiles from B60f reconstructed scans have the largest variations 
for different spatial locations: the upper TA region has higher noise and higher calibration values 
compared to the lower TA region; the lower EA region has higher noise and higher calibration 
values compared to the upper EA region; however, AB region appears to be more stable than EA 
and TA. The same trend has been observed in B40f and I41f\4 (without dose-modulation) 
reconstructed scans to a lesser extent. 
 When evaluated on a large LCS cohort with LDCT scans, both noise and calibration have 
displayed some variation among the different scans. For noise, AB region noise has both the 
largest variation (standard deviation of 15.55HU) and the highest mean value (42.07HU) while 
EA region has the lowest noise (mean = 23.17HU and standard deviation = 8.35HU). For 
calibration, TA region has shown the largest variation among the three regions (standard 
deviation of 18.63HU). It should also be noted that all histograms have exhibited a Gaussian like 
distribution except for the Tc measurement, which is likely caused by mixing the GE and 
Siemens scans together since they have very different overall Tc values. Therefore, in the setting 
of LCS, the automated quality measurements can be used to adjust imaging protocols by 
providing feedbacks of scan quality.  
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4.5    Conclusion 
 In conclusion, a fully-automated algorithm has been developed to measure CT image 
quality including the noise and calibration level from homogeneous 3D regions automatically 
extracted from CT scans. The 3D regions are: an external air region, a trachea lumen air region, 
and a descending aorta lumen blood region. Both global quality and quality per image slice is 
computed. The algorithm has been evaluated on both phantom CT scans and LCS LDCT scans 
with respect to its repeatability between longitudinal scan pairs and its sensitivity to the change 
of imaging protocols. Based on the evaluation results, the algorithm has displayed repeatability 
between longitudinal scans, sensitivity to imaging protocol changes, and overall robustness. It is 
also able to provide distinctive quality profiles for different scanners and imaging protocols. This 
algorithm may be used to monitor image quality retrospectively and to aid the design of 
computer algorithms.
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CHAPTER 5 
 
CONCLUSIONS 
 Fully-automated computer methods have been developed and validated to perform 
quantitative image biomarker measurements in chest CT scans in this research, with a special 
focus on the low-dose chest CT scans associated with LCS. The regulatory implementation of 
LCS [1] provides the opportunity to apply these methods to a large at risk population who are 
receiving annual LDCT. Since they are also at risk for other diseases such as coronary heart 
diseases, it is beneficial to provide companion diagnostics using these LDCT scans in addition to 
the detection and monitoring of pulmonary nodules.  
The main contributions of this research are the development and validation of computer 
methods for the following tasks:  
1) Fully-automated measurement of cardiac biomarkers (primarily CAC) through the region 
segmentation of cardiac organs (aorta, heart and PT); 
2) Implementation of experiments to evaluate the impact of nodule size on nodule 
characterization in the context of small pulmonary nodules;  
3) Fully-automated detection of early-stage lung diseases including ILD and pleural 
thickening;  
4) Fully-automated quality assessment of CT scans (noise and calibration).  
All segmentation and image biomarker measurement algorithms explored are fully-
automated. The image segmentation algorithms have been evaluated on large datasets with more 
than 20,000 CT scans. 
5.1    Cardiac segmentation and disease biomarker measurement 
 It is beneficial to provide cardiac health assessment for LCS participants since they are 
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also at high risk for cardiovascular diseases. For the assessment of aorta for diameter 
abnormalities and calcifications, a three-stage algorithm has been developed to track and 
segment the aorta surface from LDCT. Then the pulmonary artery trunk and the general heart 
region are segmented using the constraint from the segmented aorta as well as other adjacent 
organs. Aorta diameter profile and PT average diameter are computed from the segmented 
regions. Based on the heart region mask and the other segmented cardiac organs, the CAC is 
segmented and labeled by the artery it is associated with. In addition, calcification on the surface 
of the aorta and fat around the visceral heart region is segmented. 
 The cardiac segmentation has been evaluated both quantitatively and qualitatively. 
Quantitative evaluation shows that the segmented regions have good agreement with the 
manually marked boundaries (DSC = 0.93 for aorta, 0.88 for PT, and 0.93 for CVF). Qualitative 
evaluation shows when evaluated on a large dataset with over 20,000 CT scans, the algorithms 
produce good or acceptable results on 92% of the scans based on visual inspections. The cardiac 
biomarker measurements have been compared to manual measurements such as manual 
markings or visual scores. The CAC scores are 0.90 correlated with scores from manual 
markings and 0.87 correlated with visual categorical scores. The AC scores are 0.99 correlated 
with scores from manual markings. 
This research work has shown that it is possible to perform cardiac organ segmentation 
and biomarker measurement in LDCT both precisely and robustly. There are a number of future 
directions for the cardiac analysis. First, there is still room for algorithm improvement such as 
the algorithm for CAC segmentation and labeling. The current algorithm relies on the spatial 
locations and distances to pre-segmented organs to separate out calcification in different arteries, 
which sometimes mistakes or misses the small regions of calcification in the LCX artery group. 
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Calcification in this artery usually has a small volume and is not well-constrained spatially. 
Therefore, a potentially more complex model is needed to correctly capture the LCX 
calcification. Second, it may be possible to extend the current heart segmentation algorithm to 
determine the actual heart boundary as well as the individual chambers. Finally, it is important to 
evaluate the clinical usefulness of the various cardiac biomarker measurements in a large dataset 
with known patient histories or diagnostic outcomes. Currently the algorithms have shown good 
agreement with visual reviews by radiologists. Naturally the next step is to demonstrate their 
usefulness such as their abilities to capture early-stage diseases or to predict disease 
progressions. 
5.2    Lung disease biomarker measurement 
 The primary purpose of annual LCS is to detect a pulmonary nodule in its early-stages 
when it is more curable by surgery. Therefore, the focus of nodule status characterization should 
be on small pulmonary nodules with a diameter much less than 30mm (LCS detected nodules are 
often less than 10 mm) instead of the much larger nodules observed in cancer center CT scans. 
However, the nodule characterization studies in the literature often do not consider the size 
distribution of the nodule datasets and the results reported in these studies could simply be 
reflecting the natural size difference between malignant and benign nodules rather than the 
appearance difference between a malignant and a benign nodule of the same size. 
 In this research, a large dataset of 736 small pulmonary nodules (diameter 3-30mm) 
obtained from LCS is used to evaluate the impact of nodule size on characterization outcome. 
From the experiments, it is concluded that: 1) without taking malignant and benign nodule size 
difference into consideration, the characterization result is overly optimistic and reflects the size 
distribution difference of the malignant and benign nodules; 2) evaluation on a size-balanced 
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dataset (i.e. malignant and benign nodules with the same size distribution) reflects the classifier’s 
ability to distinguish malignant and benign nodules based on their appearance features; 3) when 
evaluated on a size-balanced dataset, classifiers trained on a size-balanced dataset have better 
performance than classifiers trained on an unbalanced dataset. 
 There are several future directions for this work. First, a larger dataset is needed to assess 
and potentially improve the algorithm. Although 736 nodules is a large number for medical 
image related research, it is still far too small for most modern machine learning techniques. 
Second, other techniques such as convolutional neural networks (CNNs) could be explored for 
the same nodule characterization task. Methods such as CNNs do not need the design of specific 
features and instead learn them from the image themselves. It would be interesting to compare 
the results from these methods to that from a traditional machine learning classifier with 
explicitly designed image features. 
 In addition to nodule characterization, algorithms have also been developed in this 
research to capture early-stage ILD and pleural thickening. The ILD is represented by a 
fractional high-density feature obtained from partitioned lung regions with the same volume. 
This feature can be used to distinguish UIP (a type of ILD) from normal cases with a highest 
AUC of 0.95. Pleural thickening is represented by two surrogate measurements: the distance 
between pleural surface and ribs and the volume of concave regions on the pleural surface. These 
measurements have weak to moderate correlations with visual scores (distance measurement 
0.40 correlated and concave volume measurement 0.74 correlated with visual scores). 
 Both ILD and pleural thickening detection algorithms are still in their preliminary stages 
and can be refined with more data available. In the future, when more ILD cases become 
available covering a spectrum of different disease subtypes, the algorithm can be evaluated and 
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potentially revised with more features and different partitioning strategies to distinguish between 
different ILD subtypes, which is a more challenging topic than to distinguish between ILD and 
normal cases. The evaluation of pleural thickening detection algorithm is very challenging since 
the early-stage pleural thickening is usually not visually detectable in some cases with traditional 
viewing windows, making the reference visual scores less reliable. In the future, it is important to 
gather a pleural thickening cohort with diagnostic outcomes to properly validate the 
automatically detected pleural thickening regions. 
5.3    Image quality measurement 
 CT image quality such as noise level and calibration accuracy has a direct impact on 
computer algorithm performance. Specific algorithm designs such as parameter settings often 
need to be adjusted based on the actual image noise and calibration level. For instance, the CAC 
segmentation algorithm described in Chapter 2 requires pre-filtering and the specification of a 
calcification region intensity threshold, both of which are adjusted based on image noise levels. 
 In this research, image noise and calibration are measured in three automatically 
extracted homogeneous regions: an external air region EA, a trachea lumen air region TA, and a 
descending aorta lumen blood region AB. For each region, a global measurement and a per slice 
measurement are provided. This algorithm has been evaluated on both phantom CT datasets and 
LCS LDCT datasets and observations are made that: 1) the algorithm is repeatable for 
longitudinal scans; 2) the algorithm is sensitive to imaging protocol changes such as the radiation 
exposure level, the reconstruction slice thickness, and the reconstruction filter; 3) the algorithm 
can be used to demonstrate common as well as unique quality profile traits for different scanners 
and imaging protocols. 
 This algorithm serves as a first step for automated image quality measurement and 
  115 
feedback. In the future, it can be used as a guidance to the modification of algorithm parameter 
settings. For example, the noise measurement can be used to modify the image pre-filtering level 
in cardiac segmentation and lung health evaluation. The calibration measurement can be used to 
modify biomarker measurements that depend on an absolute threshold such as the emphysema 
indices and the fractional high-density measurement used for ILD characterization. It can also be 
used to exclude images that do not meet specific quality criteria from being further analyzed.
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